Large intestine disorder
MONDO:0024634A disease that involves the large intestine.
Also known as: disease of large intestine, disease or disorder of large intestine, disorder of large intestine, large intestine disease or disorder
3293 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 663 trials in this tab.
-
New vaccine aims to protect infants from deadly diarrhea
⭐️ VACCINE ⭐️ CompletedThis study tests a new vaccine called Shigella4V, designed to protect against shigellosis, a severe diarrheal disease. Researchers are giving the vaccine to healthy adults, children, and 9-month-old infants to check its safety and whether it triggers a strong immune response. Dif…
Phase: PHASE1, PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
New shigella vaccine shows promise in first human trials
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect against severe diarrhea caused by Shigella bacteria. The vaccine was first given to adults in Europe, then to adults, children, and infants in Africa. Researchers checked for side effects and measured immune responses to find th…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:01 UTC
-
HPV vaccine shows promise for japanese men in landmark trial
⭐️ VACCINE ⭐️ CompletedThis phase 3 study tested the 9-valent HPV vaccine (Gardasil 9) in over 1,000 Japanese males aged 16 to 26. The goal was to see if the vaccine could prevent persistent HPV infections that can lead to genital warts and anal cancers. Participants received either the vaccine or a pl…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:07 UTC
-
New shigella vaccine shows promise for infants in phase 2 trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called Shigella4V2 to protect infants against shigellosis, a severe diarrheal disease. Researchers gave the vaccine to 110 healthy 9-month-old babies to check its safety and how well it triggers an immune response. The goal is to find the best dose…
Phase: PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:03 UTC
-
New oral vaccine aims to tackle two Diarrhea-Causing bugs at once
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new oral vaccine designed to protect against two bacteria that cause severe diarrhea: Shigella and ETEC. Fifty-three healthy adults received the vaccine to check for side effects and to see if it triggers an immune response. The goal is to develop …
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:01 UTC
-
New vaccine aims to stop deadly infant diarrhea
⭐️ VACCINE ⭐️ CompletedThis study tested a new Shigella vaccine in 200 healthy African infants to see if it can prevent severe diarrhea. The vaccine was given in two doses, and researchers measured immune responses and safety. The trial is now complete, and results will show whether this approach is pr…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
Temporary bypass device aims to protect surgical connections in colorectal cancer
Disease control CompletedThis trial tests a temporary device called CG-100 that is placed inside the intestine during colorectal cancer surgery. The device is designed to protect the surgical connection while it heals, potentially reducing leaks and other complications. The study includes adults aged 22 …
Phase: NA • Sponsor: Colospan Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a website help cancer survivors live healthier? large study tests online lifestyle coaching
Disease control CompletedThis study tests whether a secure website with educational sessions, goal-setting, and tracking tools can help survivors of several cancers (including breast, prostate, colorectal, and others) improve their diet, increase physical activity, and manage weight. Participants are age…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Which radiotherapy technique offers best value for pelvic cancers?
Disease control CompletedThis trial compares three modern radiotherapy techniques—helical tomotherapy and two types of dynamic arc therapy (RapidArc and VMAT)—for treating prostate, cervical, and anal canal cancers that require pelvic lymph node irradiation. The goal is to determine which method is most …
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New cocktail aims to make immunotherapy work for common colorectal cancer
Disease control CompletedThis phase 2 trial is testing whether a combination of chemotherapy (mFOLFOX6), a targeted therapy (bevacizumab), and an immunotherapy (PD-1 inhibitor) can help people with a specific type of locally advanced colorectal cancer called microsatellite stable (MSS). Unlike other colo…
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug shrinks tumors in patients with rare gene mutation
Disease control CompletedThis study tested the drug larotrectinib in 215 adults with various solid cancers that have a specific change in the NTRK gene. The drug is taken orally and works by blocking the action of the altered gene. The main goal was to see how many patients had their tumors shrink or dis…
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Promising combo tackles tough cancers in early trial
Disease control CompletedThis early-phase study tested the safety of combining two drugs—pembrolizumab (an immunotherapy) and AMG386 (which targets blood vessel growth)—in 62 people with advanced solid tumors like melanoma, ovarian, renal, or colorectal cancer. The main goals were to find the safest dose…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a cup of green tea keep colon cancer away?
Disease control CompletedThis pilot study tests whether a purified green tea extract called EGCG can help prevent colon cancer from coming back after surgery. 51 patients who had their colon cancer removed took either the extract or a placebo. Researchers are checking for changes in DNA methylation, a ma…
Phase: EARLY_PHASE1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers
Disease control CompletedThis study tests a combination of three immunotherapy drugs—PDS0101, M7824, and NHS-IL12—in people with advanced HPV-related cancers such as cervical, anal, and throat cancers. The goal is to see if the mix can shrink tumors or stop them from growing. Participants receive the dru…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Poop pills from different donors: a new hope for ulcerative colitis?
Disease control CompletedThis study tested fecal microbiota transplantation (FMT) from different donors to treat ulcerative colitis, a type of inflammatory bowel disease. Researchers gave 102 patients a one-time colonoscopic infusion of fresh fecal bacteria from healthy donors. The goal was to see if don…
Phase: NA • Sponsor: First Affiliated Hospital of Kunming Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple supplement make chemo work better for advanced colon cancer?
Disease control CompletedThis trial investigates whether adding a dietary supplement called sodium nucleinate to standard FOLFOX chemotherapy helps people with metastatic colorectal cancer (cancer that has spread). Participants are randomly assigned to receive either the supplement or a placebo alongside…
Phase: PHASE2, PHASE3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Vitamin d may unlock iron absorption in IBD patients
Disease control CompletedThis study investigates whether giving vitamin D supplements to adults with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who also have low vitamin D levels can improve their iron status. Participants take high-dose vitamin D3 weekly for 8 weeks, then a lower…
Phase: PHASE4 • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Stool transplants via stoma show promise for treating Post-Surgery colon inflammation
Disease control CompletedThis study tests whether giving patients their own stool bacteria through a temporary stoma can reduce inflammation in the unused part of the colon, a condition called diversion colitis. Sixty-six people with rectal cancer who have a temporary ileostomy will receive either a dail…
Phase: NA • Sponsor: Yongjian Liao • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New device aims to simplify bowel surgery
Disease control CompletedThis study is testing a new device called SEGER IDEA™ that helps surgeons close openings in the bowel during keyhole surgery. It is the first time this device is being used in humans. Ten adults having certain types of bowel surgery will take part. The main goal is to see if the …
Phase: NA • Sponsor: Seger Surgical Solutions • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug cocktail aims to make inoperable abdominal cancers operable
Disease control CompletedThis phase 2 trial tested a combination of two drugs—paclitaxel (given intravenously and directly into the abdomen) and oral nilotinib—in 21 adults with cancers that had spread to the lining of the abdomen and could not be surgically removed. The goal was to see if the treatment …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New antibody aims to calm ulcerative colitis when other treatments fail
Disease control CompletedThis phase 2 trial tests whether OSE-127, an antibody that blocks a key immune signal, can reduce disease activity in people with moderate to severe ulcerative colitis who have not responded to or cannot tolerate previous treatments. Participants are randomly assigned to receive …
Phase: PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can adding cetuximab to chemotherapy prevent colon cancer return?
Disease control CompletedThis large phase III trial studied whether adding the targeted drug cetuximab to standard chemotherapy after surgery helps prevent cancer from coming back in patients with stage III colon cancer. Over 3,300 patients took part, and the study focused on those with a specific geneti…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Immunotherapy cocktail shows promise against tough rectal cancers
Disease control CompletedThis study tested whether giving a mix of immunotherapy drugs (tislelizumab and IL-2) plus chemotherapy before surgery could shrink tumors more effectively in people with locally advanced rectal cancer. The trial involved 130 adults whose cancers had not spread but were hard to t…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Immunonutrition before surgery may cut complications and preserve muscle in colorectal cancer patients
Disease control CompletedThis trial compares two types of oral nutritional supplements given to colorectal cancer patients before surgery. One group receives standard high-protein drinks, while the other gets immunonutrition drinks enriched with arginine, nucleotides, vitamin D, and omega-3 fatty acids. …
Phase: NA • Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a structured chat with a nurse boost medication adherence in IBD?
Disease control CompletedThis trial tests whether a nurse-led education program, based on the Health Belief Model, can improve treatment adherence in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are receiving anti-TNF therapy. The program aims to address patients' co…
Phase: NA • Sponsor: Izmir Katip Celebi University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo takes on advanced cancers in early trial
Disease control CompletedThis early-phase trial tested an experimental drug called KVA12123, given alone or with the immunotherapy Keytruda, in 40 adults with advanced solid tumors (like lung, breast, or colon cancer) that had stopped responding to standard treatments. The main goals were to check safety…
Phase: PHASE1, PHASE2 • Sponsor: Kineta Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cocktail shows promise against tough rectal tumors
Disease control CompletedThis completed study looked at whether adding an immune-boosting drug called thymalfasin to standard chemoradiotherapy and a PD-1 inhibitor could help shrink advanced rectal tumors before surgery. Researchers studied 47 patients with stage II/III mid-low rectal cancer. The main g…
Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail targets Hard-to-Treat colorectal cancer
Disease control CompletedThis study tests whether a combination of three drugs—cisplatin, nivolumab, and temozolomide—can shrink tumors in people with advanced colorectal cancer that has not responded to other treatments. The cancer must be a specific type called MMR-proficient. The trial involves 18 par…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could tempeh and vitamin d ease IBD symptoms?
Disease control CompletedThis study tested whether taking tempeh powder (a source of isoflavones) and vitamin D3 daily for 8 weeks could improve vitamin D levels, reduce inflammation, and boost quality of life in people with inflammatory bowel disease (IBD). Fifty adults with ulcerative colitis or Crohn'…
Phase: NA • Sponsor: Indonesia University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Prepping the body and mind before colon cancer surgery may cut recovery risks
Disease control CompletedThis trial tests whether a program of exercise, nutrition advice, and psychological support—started four weeks before surgery and continued afterward—can reduce complications in people having colon cancer surgery. Participants are adults over 40 with non-metastatic colon cancer w…
Phase: NA • Sponsor: Universidad de Granada • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New gut bacteria therapy shows promise for colitis
Disease control CompletedThis early-stage study tested a new treatment called MB310 in 29 adults with mild-to-moderate ulcerative colitis. The main goal was to see if it is safe and how well it takes hold in the body. Participants received either MB310 or a placebo, and researchers monitored side effects…
Phase: PHASE1 • Sponsor: Microbiotica Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo takes on tough cancers in early trial
Disease control CompletedThis early-phase trial tested a new drug called vilastobart, alone or with another drug (atezolizumab), in 125 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. Researchers also looke…
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug targets urgent bathroom needs in colitis patients
Disease control CompletedThis study tested the drug mirikizumab in 172 adults with moderate-to-severe ulcerative colitis who still had bowel urgency despite other treatments. The main goal was to see if the drug reduces the sudden, urgent need to use the bathroom. Participants were followed for 36 weeks …
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Seaweed supplement may help leaky gut in bowel disorders
Disease control CompletedThis study tested whether a seaweed-derived supplement called Aquamin® can reduce gut permeability (often called 'leaky gut') in people with ulcerative colitis, irritable bowel syndrome with diarrhea, and healthy volunteers. Thirty-five adults took Aquamin capsules for 90 days. R…
Phase: PHASE2 • Sponsor: James Varani • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Personalized cancer vaccine shows promise in early trial
Disease control CompletedThis early-phase study tested a personalized cancer vaccine (RO7198457) in 273 patients with advanced solid tumors like melanoma, lung, and breast cancer. The vaccine was given alone or with an immunotherapy drug (atezolizumab) to see if it was safe and how the body responded. Th…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Common painkiller may boost Chemo's power against cancer
Disease control CompletedThis early-phase study tested whether adding indomethacin, a common anti-inflammatory drug, to standard platinum-based chemotherapy is safe for people with colorectal, esophageal, or ovarian cancers. The 13 participants received escalating doses of indomethacin alongside their ch…
Phase: PHASE1 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Real-World study checks how well tofacitinib controls ulcerative colitis
Disease control CompletedThis completed observational study looked at how well the drug tofacitinib works for people with ulcerative colitis in everyday Swedish clinics. Researchers used a national registry to track disease remission and whether patients stayed on the medication. The study included 102 p…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug shows promise for kids with severe bowel disease
Disease control CompletedThis study tested the drug mirikizumab in 63 children aged 2 to 17 with moderate-to-severe ulcerative colitis, a chronic bowel disease. The goal was to see if the drug could help control the disease and improve symptoms. All children received the drug, and researchers measured re…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Anal fistula surgery showdown: which technique spares continence?
Disease control CompletedThis study compared two common surgeries for perianal fistula—a painful tunnel near the anus. One hundred adults were split into two groups: one received the LIFT procedure (which aims to preserve muscle control) and the other received fistulotomy with a seton (a thread placed in…
Phase: NA • Sponsor: Islamabad Medical and Dental College • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Antibody therapy aims to keep colon cancer from returning
Disease control CompletedThis phase III trial tested whether adding a monoclonal antibody called edrecolomab to surgery helps people with stage II colon cancer live longer or stay cancer-free longer. About 2,100 participants were randomly assigned to receive either the antibody or no additional treatment…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Which antibiotic works best for hidden anal chlamydia?
Disease control CompletedThis study compared two common antibiotics—azithromycin (single dose) and doxycycline (7-day course)—for treating anal chlamydia in women who also had a vaginal chlamydia infection. The goal was to see which treatment clears the anal infection better, since anal chlamydia often g…
Phase: PHASE4 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New cocktail shows promise against Tough-to-Treat colon cancer
Disease control CompletedThis phase 2 trial tested a combination of three drugs—encorafenib, binimetinib, and cetuximab—in 95 patients with a specific type of advanced colorectal cancer (BRAF V600E mutation) who had not received prior treatment for their metastatic disease. The goal was to see how many p…
Phase: PHASE2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Simple arm exercise may boost lung recovery after colon cancer surgery in seniors
Disease control CompletedThis study tested whether a 20-minute arm cycling exercise, done twice daily for five days, could improve lung function and recovery in 60 elderly patients after colon cancer surgery. Participants also received standard physical therapy. The goal was to see if the arm exercise co…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a common arthritis pill tame Chemo's worst side effect?
Disease control CompletedThis study tested whether adding the arthritis drug Celebrex to an experimental chemo drug called EPO906 could reduce severe diarrhea in people with advanced colorectal cancer. The trial enrolled 75 patients who had already tried other treatments. The first phase found the safest…
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New drug combo tested for tough cancers
Disease control CompletedThis early-stage trial tested a new drug called AZD6244 combined with standard chemotherapies in 140 people with advanced solid tumors (breast, colon, lung, melanoma, kidney). The main goal was to see if the combination is safe and tolerable, and to find the best dose. Researcher…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New combo therapy aims to outperform standard care in tough colorectal cancer
Disease control CompletedThis Phase 3 trial tested a new drug combination called MK-4280A (favezelimab plus pembrolizumab) against standard treatments (regorafenib or TAS-102) in 441 people with advanced colorectal cancer that had stopped responding to prior therapy. The goal was to see if the new combin…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New stitch pattern may prevent dangerous wound opening after colon surgery
Disease control CompletedThis study tested two different ways of stitching the belly wall closed after colorectal cancer surgery to see which one better prevents the wound from bursting open. Forty adults having open surgery were randomly assigned to either an interrupted 'figure-of-X' stitch or a contin…
Phase: NA • Sponsor: Islamabad Medical and Dental College • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New surgical twist may speed healing of anal fistulas
Disease control CompletedThis study tested two surgical methods for treating a type of anal fistula called transsphincteric anal fistula. Forty adults were randomly assigned to receive either the standard LIFT procedure or a modified version that approaches the fistula from the side. Researchers measured…
Phase: NA • Sponsor: Tugberk Tok • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental combo targets Hard-to-Treat GI cancers
Disease control CompletedThis early-phase trial tested two drugs together—pembrolizumab (Keytruda) and XL888—in 47 people with advanced gastrointestinal cancers like colorectal and pancreatic cancer that had spread or could not be removed. The main goal was to find the safest dose and check for side effe…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a drug combo shrink liver tumors enough for surgery?
Disease control CompletedThis study tested whether adding bevacizumab to a powerful four-drug chemotherapy regimen (FOLFOXIRI) could shrink liver tumors in people with colorectal cancer that had spread only to the liver and could not be removed surgically. The goal was to see if more patients could then …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can an arthritis drug boost chemo for colon cancer?
Disease control CompletedThis study tested whether adding the anti-inflammatory drug celecoxib to standard FOLFOX chemotherapy helps prevent cancer from returning in people with stage III colon cancer after surgery. Over 2,500 participants were randomly assigned to receive either celecoxib or a placebo a…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Glowing dye during surgery may cut dangerous bowel leaks
Disease control CompletedThis study tested whether injecting a special dye (ICG) during laparoscopic colorectal cancer surgery helps surgeons see blood flow and choose a safer spot to cut. Over 560 adults took part, with half getting the dye and half relying on the surgeon's usual judgment. The main goal…
Phase: NA • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New device could spare colon cancer patients from temporary stoma
Disease control CompletedThis study tested a temporary device called Colovac 2 in 24 people undergoing colon cancer surgery. The device is placed inside the bowel to protect the surgical connection while it heals, potentially avoiding the need for a temporary stoma. Researchers checked if the device stay…
Phase: NA • Sponsor: SafeHeal Inc • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New registry maps how targeted liver treatment is used in colorectal cancer
Disease control CompletedThis registry followed 152 patients with colorectal cancer that had spread mainly to the liver. Doctors used tiny beads called LifePearl Microspheres loaded with the chemotherapy drug irinotecan, delivered directly to the liver's blood supply. The goal was to see how and when thi…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Drain or no drain? landmark trial settles debate after rectal cancer surgery
Disease control CompletedThis study tested whether placing a temporary drain in the pelvis after rectal cancer surgery reduces the risk of serious infections like leaks or abscesses. About 500 patients were randomly assigned to receive a drain or not. The main goal was to see if drainage lowered pelvic s…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Vedolizumab safety check in kids with IBD shows promise
Disease control CompletedThis study looked at the long-term safety of vedolizumab, a biologic drug given by IV, in 59 children with ulcerative colitis or Crohn's disease. Participants had already completed a previous study and continued treatment to monitor for side effects. The goal was to see if the dr…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New registry shows promise for microwave ablation in liver cancer spread
Disease control CompletedThis registry followed 500 adults with colorectal cancer that spread to the liver. All were treated with a microwave ablation device that uses heat to destroy tumors. The goal was to see how well the device controls tumors locally over 12 months and to track any side effects. The…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug shows promise for keeping ulcerative colitis in check
Disease control CompletedThis study tested whether mirikizumab can help people with moderate to severe ulcerative colitis stay in remission (symptom-free) after they had already responded to an initial treatment. About 1,300 adults who completed a prior induction study were randomly assigned to receive m…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for kids with severe colitis: drug shows promise in major trial
Disease control CompletedThis study tested a drug called ustekinumab in 112 children with moderate-to-severe ulcerative colitis, a condition causing inflammation in the colon. The goal was to see if the drug could reduce symptoms like diarrhea and bleeding and help the colon heal. Children first received…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for rectal cancer: extra chemo may save the rectum
Disease control CompletedThis phase 3 trial tested whether adding two months of Folfirinox chemotherapy before standard radiation and chemo could help more patients with early-stage rectal cancer avoid major surgery. 218 adults with small, low-lying tumors were enrolled. The goal was to see if more patie…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Which laxative cleans the colon best? new study aims to find out
Disease control CompletedThis study compared two low-volume laxatives used to clean the colon before a colonoscopy: one liter of polyethylene glycol with ascorbate (PEG1A) and sodium picosulfate with magnesium citrate (PSCM). The goal was to see which one provides a higher quality colon cleansing, which …
Phase: PHASE4 • Sponsor: Parc de Salut Mar • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy tested for hard-to-treat colorectal cancer
Disease control CompletedThis early-phase trial tested a combination of two drugs (MEK162 and mFOLFIRI) in 25 adults with advanced RAS-positive colorectal cancer that had stopped responding to standard treatment. The main goal was to find the safest dose and check for side effects. Researchers also looke…
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Experimental COM902 drug shows promise in early cancer trial
Disease control CompletedThis early-phase study tested an experimental drug called COM902, alone or with other drugs, in 94 people with advanced cancers like ovarian, lung, and colon cancer. The main goal was to check safety and find the right dose. Researchers also looked for early signs that the drug m…
Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New antibody shows promise in early trial for tough colorectal cancer
Disease control CompletedThis early-stage study tested a new antibody drug (similar to cetuximab) in 18 people with advanced colorectal cancer that had stopped responding to standard treatments. The main goal was to check safety and how the drug moves through the body. Participants received one of two do…
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug candidate CBX-12 tested in patients with Hard-to-Treat cancers
Disease control CompletedThis study tested an experimental drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, breast, or colon cancer) that had stopped responding to standard therapies. The main goals were to check the drug's safety, find the best dose, and see if it could sh…
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Yeast vaccine shows promise in stopping Cancer's return
Disease control CompletedThis early-stage study tested a custom-made yeast vaccine designed to train the immune system to recognize and attack leftover cancer cells. Five adults with various cancers (like colorectal, breast, or lung) who had completed initial treatment received the vaccine. The goal was …
Phase: PHASE1 • Sponsor: NantBioScience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Rectal cancer patients may avoid surgery with new Chemo-Radiation combo
Disease control CompletedThis study tested a treatment plan for locally advanced rectal cancer that uses a short course of radiation followed by chemotherapy, aiming to avoid surgery. 39 patients were enrolled. The goal was to see if the cancer could be completely controlled without an operation, using a…
Phase: PHASE2 • Sponsor: Servicio de Salud Metropolitano Sur Oriente • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug combo shows early promise against Hard-to-Treat cancers
Disease control CompletedThis early-stage study tested a new drug called BI 765049, alone or combined with another drug (ezabenlimab), in 21 Asian adults with advanced solid tumors (stomach, colorectal, pancreatic, liver, head and neck, or lung cancer) that have a specific marker called B7-H6. The main g…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug A140 challenges standard treatment for colorectal cancer
Disease control CompletedThis study tested whether a new drug called A140 works as well as the standard drug Erbitux for people with a certain type of advanced colorectal cancer (RAS wild-type). Both drugs were given together with chemotherapy. The trial involved 688 adults and measured how many patients…
Phase: PHASE3 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Cancer drug vismodegib tested for Long-Term use in small study
Disease control CompletedThis study looked at the long-term safety of the cancer drug vismodegib in 19 patients with ovarian cancer, basal cell carcinoma, or metastatic colorectal cancer. All participants had previously taken vismodegib in an earlier Genentech trial and were expected to benefit from cont…
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a common arthritis drug tame rare immune disease Flare-Ups?
Disease control CompletedThis study tested the drug tofacitinib (Xeljanz) in 10 adults with chronic granulomatous disease (CGD) who had ongoing inflammation in the gut, skin, or lungs. Participants took the pill daily for 3 months to see if it was safe and could help control symptoms. The goal was to fin…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
DNA vaccine shows promise against anal precancer in HIV patients
Disease control CompletedThis study tested a DNA-based vaccine called VGX-3100 in 44 HIV-positive adults with high-grade anal precancer caused by HPV types 16 or 18. The vaccine was given with a mild electric pulse (electroporation) to help cells absorb it and boost the immune system's attack on the abno…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Immunotherapy combo shows promise against tough rectal cancers
Disease control CompletedThis study tested whether adding an immunotherapy drug called APX005M to standard treatment helps people with advanced rectal cancer achieve a complete response (no cancer left after treatment). 58 adults with stage II or III rectal cancer at high risk took part. The goal was to …
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New stitching trick may improve colon cancer surgery
Disease control CompletedThis study tested a new way to reconnect the colon after removing a cancerous section using a robot. The technique uses a special double purse-string stitch and a single stapler. Thirty-nine patients with sigmoid colon cancer were included, and the study looked at how well the te…
Phase: NA • Sponsor: Vejle Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common cholesterol drug ease ulcerative colitis?
Disease control CompletedThis study tested whether adding fenofibrate, a drug typically used for high cholesterol, to the standard treatment mesalamine can improve symptoms and quality of life in people with mild-to-moderate ulcerative colitis. The trial enrolled 60 adults and measured changes in disease…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a combination of two drugs, lenvatinib and pembrolizumab, in 611 people with advanced cancers like breast, ovarian, stomach, colorectal, brain, bile duct, or pancreatic cancer that had stopped responding to standard treatments. The goal was to see if the combo c…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New daily pill aims to keep ulcerative colitis in check
Disease control CompletedThis study tested a daily pill called ABX464 (obefazimod) as a long-term maintenance therapy for people with moderate to severe ulcerative colitis. 217 patients who completed a prior 16-week induction study took the drug for up to 96 weeks. The main goal was to see how many patie…
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for Tough-to-Treat colon cancer?
Disease control CompletedThis study tested an experimental drug called CTX-009 in 49 adults with metastatic colorectal cancer that had worsened after two or three prior treatments. The goal was to see if the drug could shrink tumors or stop them from growing. Results will help determine if further testin…
Phase: PHASE2 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New cancer drug HBM1020 tested in tiny early trial
Disease control CompletedThis early-phase study tested a new drug, HBM1020, in 17 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The drug was given by IV every three weeks. Because this is a Phase 1 trial, i…
Phase: PHASE1 • Sponsor: Harbour BioMed US, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New device may help colorectal cancer patients avoid a temporary colostomy
Disease control CompletedThis study tested a device called Colovac+ in 27 adults having surgery for colorectal cancer. The device is placed inside the bowel to protect the surgical connection and keep stool away while it heals. The goal was to see if it is safe and effective, and whether it could help pa…
Phase: NA • Sponsor: SafeHeal Inc • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Washing therapy dogs may keep hospital germs away from kids
Disease control CompletedThis study tested whether cleaning therapy dogs with a special disinfectant (chlorhexidine) before hospital visits could reduce the spread of harmful germs to children. The trial involved 45 children aged 3 to 17 who interacted with therapy dogs. Researchers checked if the cleani…
Phase: PHASE4 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Radiation-Chemo combo may let rectal cancer patients skip surgery
Disease control CompletedThis study tested whether a short course of radiation followed by chemotherapy could eliminate the need for surgery in people with early-stage rectal cancer. 63 patients were enrolled, and the treatment aimed for a complete clinical response, meaning no tumor could be found on ex…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New combo therapy shows promise in early trial for liver-metastatic colorectal cancer
Disease control CompletedThis early-phase study tested the safety of combining the immunotherapy drug pembrolizumab with precise, high-dose radiation (SBRT) to the liver in 15 adults with colorectal cancer that had spread only to the liver. The goal was to see if this combination could prevent the cancer…
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Home test for gut inflammation could cut flares in ulcerative colitis
Disease control CompletedThis study tested whether people with ulcerative colitis can use a home stool test to catch inflammation early and prevent symptom flares. Over 700 adults in remission used a smartphone-based test kit to measure calprotectin levels. The goal was to see if this proactive monitorin…
Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Herbal bath may help anal surgery wounds heal faster
Disease control CompletedThis study tested whether a daily bath with a traditional Chinese herbal mixture called Tongyangxiao can help surgical wounds heal faster after anal fistula surgery. 115 patients used either the herbal bath or a standard antiseptic bath for 14 days after surgery. Researchers meas…
Phase: NA • Sponsor: Yongkang An • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Cold vs. hot snare: which is better for removing colon polyps?
Disease control CompletedThis study compared two methods for removing non-cancerous colon polyps that are 10-19 mm in size: cold snare (no heat) and hot snare (uses heat). 216 adults undergoing colonoscopy were randomly assigned to one method. The goal was to see if cold snare is as effective and safe as…
Phase: NA • Sponsor: Qingwei Jiang • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New combo shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis study tested a new two-drug combination (encorafenib and cetuximab) against standard treatments in 107 Chinese patients with a specific genetic mutation (BRAF V600E) that makes colorectal cancer harder to treat. The goal was to see if the new combo could slow cancer growth b…
Phase: PHASE2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Jun 27, 2026 12:27 UTC
-
New hope for kids with severe gut disease: drug shows promise in remission
Disease control CompletedThis study tested a medicine called vedolizumab in 121 children with moderate to severe ulcerative colitis, a condition causing inflammation and pain in the gut. The goal was to see if the drug could help children achieve remission, meaning their symptoms improve and tests show l…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New combo shrinks liver tumors in hard-to-treat colorectal cancer
Disease control CompletedThis study tested a treatment for people with colorectal cancer that spread to the liver and had not responded to at least two prior therapies. The treatment combined a strong chemotherapy cocktail delivered directly to the liver (FOLFOXIRI via hepatic arterial infusion) with an …
Phase: PHASE2 • Sponsor: Meng Qiu • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug duo targets Hard-to-Treat colorectal cancer
Disease control CompletedThis phase 3 trial tested whether combining sotorasib (a pill) and panitumumab (an infusion) can slow tumor growth better than standard chemotherapy in 160 adults with metastatic colorectal cancer that has a specific KRAS G12C mutation. Participants were randomly assigned to rece…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Immunotherapy shows promise against Hard-to-Treat colorectal cancer
Disease control CompletedThis phase 2 study tested the immunotherapy drug prolgolimab in 30 people with a specific type of colorectal cancer (MSI/dMMR) that had not spread. Participants received the drug for 6 months before planned surgery. The main goal was to see if the cancer completely disappeared in…
Phase: PHASE2 • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could a common Anti-Inflammatory pill boost biologic therapy for ulcerative colitis?
Disease control CompletedThis study looked at whether adding mesalazine (a standard anti-inflammatory drug) to biologic treatments like infliximab or vedolizumab helps people with moderate to severe ulcerative colitis achieve endoscopic remission (healing of the gut lining). The trial enrolled 438 adults…
Phase: PHASE4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New way to deliver c. diff treatment: through a colonoscopy
Disease control CompletedThis study tested a treatment called RBX2660 (REBYOTA) for people with recurrent Clostridioides difficile infection. The treatment is made from healthy human stool bacteria and was given during a colonoscopy. The goal was to see if this delivery method is safe and works well. For…
Phase: PHASE3 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy shows promise for Tough-to-Treat colon cancer
Disease control CompletedThis early-phase study tested a combination of two drugs, cabozantinib and TAS-102, in 15 people with advanced colorectal cancer that had spread and stopped responding to standard treatments. The main goal was to find the safest dose and identify side effects. The study is comple…
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Exercise program tested to keep colon cancer at bay
Disease control CompletedThis study tested whether a 3-year physical activity program could help prevent colon cancer from coming back in 889 patients who had surgery and chemotherapy for high-risk stage II or stage III colon cancer. Participants were randomly assigned to either the exercise program plus…
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New 'Bottom-Up' surgery for rectal cancer could mean faster recovery
Disease control CompletedThis study tested a newer, less invasive surgery called ETAP (done through the anus) against standard laparoscopic surgery (done through the belly) for low rectal cancer. 226 adults took part. The goal was to see if ETAP is as good at removing all cancer while possibly leading to…
Phase: PHASE3 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immunotherapy drug shows promise for tough colorectal cancer
Disease control CompletedThis phase II trial tested the immunotherapy drug nivolumab (Opdivo) in 35 adults with advanced colorectal cancer that has a specific marker (class II expression) and is microsatellite stable, a type that usually does not respond to immunotherapy. The goal was to see if the drug …
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Water-Assisted scope may improve colon polyp removal
Disease control CompletedThis trial tested a new method called underwater ESD for removing large, flat colon polyps. Instead of using gas to inflate the colon, doctors fill it with saline water. The goal was to see if this reduces complications like bleeding or perforation and improves complete removal. …
Phase: NA • Sponsor: Istituto Clinico Humanitas • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a combination of three drugs—vemurafenib, cetuximab, and irinotecan—in 47 people with advanced solid tumors that have a specific BRAF V600 mutation and could not be removed by surgery or had spread. The main goal was to find the safest dose and under…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Less invasive surgery shows promise for anal cancer in HIV patients
Disease control CompletedThis study looked at whether removing small, early-stage anal cancers with local surgery alone is safe and effective for people with HIV. The goal was to see if this less invasive approach could avoid the need for stronger treatments like radiation or chemotherapy. Sixteen partic…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Should cancer patients get antibiotics for a dubious c. diff test? small trial seeks answers
Disease control CompletedThis study looked at whether giving the antibiotic vancomycin helps cancer patients who have diarrhea and a positive screening test for C. difficile but a negative toxin test. Only 9 patients were enrolled, far fewer than planned. Researchers measured changes in C. difficile leve…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for Tough-to-Treat colorectal cancer? drug trial uses ultrasound to predict success
Disease control CompletedThis study tested a drug called axitinib against a placebo in 52 people with advanced colorectal cancer that had spread to the liver and stopped responding to chemotherapy. The goal was to see if axitinib could help control the cancer and to test a special ultrasound technique th…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Which surgery is safer for a burst colon? new study compares options
Disease control CompletedThis study compared two surgical methods for treating a burst section of the colon caused by diverticulitis, a condition that leads to severe abdominal infection. 102 adults with this infection were randomly assigned to either a traditional two-step surgery (Hartmann procedure) o…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Engineered immune cells take on HPV cancers in early trial
Disease control CompletedThis study tested a new experimental treatment called HPVST cells in 32 people with HPV-related cancers that had returned or not responded to standard care. The cells are grown from the patient's own blood and trained to attack HPV-infected cancer cells. The goal was to find a sa…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control CompletedThis completed Phase 2b trial tested an oral tablet called JNJ-77242113 against placebo in 252 adults with moderate-to-severe ulcerative colitis. The goal was to see if the drug could reduce symptoms and inflammation better than a dummy pill. Researchers measured clinical respons…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Glue vs staples: which closes cancer surgery wounds better?
Disease control CompletedThis study compared two ways to close skin after colorectal cancer surgery: a tissue adhesive (skin bond) and traditional skin stapling. Researchers looked at wound infection rates within 30 days, pain, and cost in 304 patients. The goal was to see if skin bond leads to fewer inf…
Phase: NA • Sponsor: Yoon Suk Lee • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new drug called TAK-676, alone and with pembrolizumab, in 248 adults with advanced solid tumors that had no standard treatment options. The main goal was to check safety and find the highest dose that causes few side effects. The study also looked at how well …
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Chemo-First approach aims to save rectums in early cancer trial
Disease control CompletedThis study tested giving chemotherapy before a less invasive surgery for early rectal cancer. The goal was to see if this approach could allow patients to keep their rectum instead of needing major surgery. 58 people took part, and the treatment was considered successful if at le…
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Polyphenol power: could these plant compounds fight pollution harm?
Disease control CompletedThis completed trial tested whether a mix of 43 plant polyphenols can counteract health damage from environmental pollutants. 98 adults took either the polyphenol supplement or a placebo for a period. Researchers measured changes in gut health, inflammation, and blood markers to …
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Dietary change may curb recurrent c. diff in cancer patients
Disease control CompletedThis study tested whether eating less fat and more fiber can reduce the chance of a repeat Clostridioides difficile infection in cancer patients. Eight participants with leukemia, lymphoma, or other cancers followed a specific diet. Researchers tracked diarrhea and measured C. di…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo attack on rectal cancer: chemo plus targeted surgery shows promise
Disease control CompletedThis study looked at 180 people with rectal cancer that had spread to lymph nodes in the pelvis. One group received a three-drug chemotherapy regimen (FOLFOXIRI) followed by surgery to remove the affected lymph nodes. The other group got standard chemoradiotherapy before surgery.…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Heated chemo wash may stop colorectal cancer spreading in abdomen
Disease control CompletedThis phase 3 trial tested whether a surgical procedure called laparotomy plus heated chemotherapy (HIPEC) could improve outcomes for colorectal cancer patients at high risk of cancer spreading in the abdomen. 150 patients who had already undergone surgery and chemotherapy were ra…
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested an experimental drug called BMS-986016 (anti-LAG-3) alone or combined with nivolumab in people with advanced solid tumors that had spread or couldn't be removed by surgery. It included several cancer types like lung, stomach, liver, kidney, bladder, head and nec…
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New device aims to cut surgery complications in colorectal patients
Disease control CompletedThis study tested whether a device that uses light to monitor blood flow (photoplethysmography) could help doctors manage fluids better during colorectal surgery. The goal was to reduce complications after surgery. 160 adults having colorectal surgery took part. The approach is n…
Phase: PHASE3 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy shows promise in advanced cancer trial
Disease control CompletedThis early-phase study tested a new drug called gevokizumab alongside standard cancer treatments in 167 adults with advanced colorectal, stomach, or kidney cancer that had spread. The goal was to find a safe and active dose and see if the combination could help control the diseas…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Experimental drug BAT8010 tested in patients with advanced cancers
Disease control CompletedThis early-phase trial tested an experimental drug called BAT8010 in 23 people with advanced or metastatic solid tumors who had no other standard treatment options. The main goals were to check safety, find the best dose, and see if the drug shows any sign of shrinking tumors. Pa…
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Underwater colonoscopy technique could make polyp removal safer and faster
Disease control CompletedThis study tested a new method called underwater endoscopic submucosal dissection (UESD) for removing large colon growths. Instead of using gas to inflate the colon, the doctor fills it with saline (salt water) to improve visibility and make the procedure easier. The trial involv…
Phase: NA • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Arginine drink may cut surgery complications in malnourished patients
Disease control CompletedThis study looked at whether a high-protein drink with added arginine can reduce problems like infections and slow bowel movement after colorectal surgery. It included 44 adults who were malnourished or at risk of malnutrition before their operation. Participants received either …
Phase: NA • Sponsor: University of Cadiz • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a DNA test predict who will respond to cancer immunotherapy?
Disease control CompletedThis completed Phase 2 trial tested whether a special DNA-based test could predict how well patients with stomach or rectal cancer respond to immunotherapy (tislelizumab) combined with chemotherapy and/or radiation. 189 adults with advanced cancer participated. The goal was to se…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Tailor-Made vaccine aims to stop cancer return in High-Risk patients
Disease control CompletedThis early-phase study tested a personalized immunotherapy (iNeo-Vac-P01) in 6 patients with stage III colorectal or non-small cell lung cancer who had already completed surgery and standard adjuvant therapy. The vaccine was designed to target unique neoantigens from each patient…
Phase: PHASE1 • Sponsor: Ying Yuan, MD • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Diabetes drug shows promise against rectal cancer in new trial
Disease control CompletedThis study looked at whether adding metformin, a common diabetes medicine, to standard chemo and radiation therapy could help people with locally advanced rectal cancer. 60 adults with stage T3 or T4 rectal cancer took part. The main goal was to see if the combination led to a co…
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug shows promise for inflammatory bowel disease in Mid-Stage trial
Disease control CompletedThis phase 2b trial tested a new drug called TEV-48574 (duvakitug) in 290 adults with moderate to severe ulcerative colitis or Crohn's disease. The study aimed to see if the drug could help patients achieve clinical remission (for UC) or an endoscopic response (for CD) after 14 w…
Phase: PHASE2 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Gut bacteria capsules take on superbugs in antibiotic patients
Disease control CompletedThis study tested whether taking capsules containing healthy gut bacteria could help clear drug-resistant germs (including C. difficile) from the intestines of 42 hospitalized adults who needed at least 7 days of antibiotics. Participants received either the bacteria capsules or …
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New antibiotic CRS3123 takes on c. diff in early trial
Disease control CompletedThis phase 2 study tested an experimental antibiotic called CRS3123 against the standard treatment vancomycin for Clostridioides difficile infection (C. diff). 43 adults with a first episode or first recurrence of C. diff took either CRS3123 or vancomycin for 10 days. The main go…
Phase: PHASE2 • Sponsor: Crestone, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Poop pills? fecal transplants show promise for gut infections
Disease control CompletedThis study tested fecal microbiota transplant (FMT) in 24 adults with recurrent Clostridium difficile infection (C. diff) that didn't get better with standard antibiotics. FMT involves placing healthy donor stool into the patient's colon to restore good bacteria. The goal was to …
Phase: PHASE4 • Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail targets Hard-to-Treat gut cancers
Disease control CompletedThis study tested a new cancer drug called ERAS-007, given by mouth, together with other targeted therapies in 101 people with advanced colorectal or pancreatic cancers that have certain gene changes. The main goals were to check safety, find the best dose, and see how the drugs …
Phase: PHASE1, PHASE2 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Poop pills show promise for gut disease
Disease control CompletedThis study tested whether fecal transplants from healthy donors could help people with ulcerative colitis, a chronic condition causing inflammation in the colon. 85 participants received either donor or their own stool via tubes and enemas. The goal was to see if donor transplant…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for advanced gut cancers? early trial tests targeted antibody
Disease control CompletedThis early-stage study tested a new drug called cabotamig in 33 adults with advanced cancers of the digestive system (like colon, pancreas, or liver) that had stopped responding to standard treatments. The goal was to see if the drug is safe and how it affects the body and tumors…
Phase: PHASE1 • Sponsor: Arbele Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study: does starting this pill sooner save colitis patients from surgery?
Disease control CompletedThis study looked back at medical records of 81 people with severe ulcerative colitis to see if starting upadacitinib early works better than using it after other treatments fail. Researchers checked how many avoided surgery and achieved remission within 12 weeks. The goal is to …
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a probiotic ease gut troubles in babies with food allergies?
Disease control CompletedThis study tested a probiotic called INF108F in 20 breastfed infants with a food allergy that causes blood in their stool. The goal was to see if the probiotic could improve the balance of gut bacteria and reduce symptoms like reflux and fussiness. While the treatment aims to con…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo attack on liver tumors shows promise in early trial
Disease control CompletedThis study tested a drug called TAS-102 (Lonsurf) combined with a precise type of radiation (SBRT) in 52 people whose colorectal cancer had spread to the liver. The goal was to find the safest dose and see if the combination could control the liver tumors. The trial is complete, …
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New oral drug shows promise for ulcerative colitis in early trial
Disease control CompletedThis study tested an experimental pill called MORF-057 in 39 adults with moderate to severe ulcerative colitis. The drug aims to reduce gut inflammation by blocking a specific protein. Researchers measured changes in colon tissue health and symptom scores after 12 weeks of treatm…
Phase: PHASE2 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug cocktail shows promise for tough colon cancer
Disease control CompletedThis study tested a combination of two drugs, palbociclib and cetuximab, in 24 people with a specific type of advanced colon cancer that had spread. The goal was to see if the combo could shrink tumors or stop them from growing. Participants took palbociclib pills and received ce…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New Two-Drug cocktail shows promise against tough cancers
Disease control CompletedThis study tested a combination of two drugs—NT-I7 (efineptakin alfa) and pembrolizumab (Keytruda)—in 215 people with advanced solid tumors that had stopped responding to treatment. The goal was to check safety, find the right dose, and see if the combo could shrink tumors. The t…
Phase: PHASE1, PHASE2 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Engineered immune cells take on HPV cancers
Disease control CompletedThis trial tested a new therapy for cancers caused by HPV-16, such as cervical, anal, and throat cancers. Researchers took patients' white blood cells, genetically engineered them to recognize a protein called E7 found in HPV cancer cells, and infused them back. Patients also rec…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a High-Fiber diet soothe ulcerative colitis? new study tests UC-TREAT
Disease control CompletedThis study tested a 15-day diet called UC-TREAT, rich in high-fiber foods, fermented foods, and berries, in 36 adults—some healthy and some with quiescent (inactive) ulcerative colitis. Researchers measured changes in gut bacteria, digestive symptoms, and diet acceptability. The …
Phase: NA • Sponsor: University of Glasgow • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug combo shows promise against deadly gut infection
Disease control CompletedThis study tested whether adding the drug bezlotoxumab to standard treatment could prevent serious outcomes in people with a severe C. diff infection. Researchers used a special score to identify 44 high-risk patients. The goal was to see if the drug reduced organ failure, infect…
Phase: PHASE2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can pelvic floor exercises help pouch patients regain control?
Disease control CompletedThis study tested whether physiotherapist-led pelvic floor and bowel training could improve bowel function in people who had ileo-anal pouch surgery for ulcerative colitis or familial adenomatous polyposis. Fifty-three participants were randomly assigned to either the behavioural…
Phase: NA • Sponsor: St Vincent's Hospital Melbourne • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Epigenetic and immune drugs join forces against tough tumors
Disease control CompletedThis completed Phase 2 trial tested whether combining an immunotherapy drug (durvalumab) with an epigenetic drug (tazemetostat) can control advanced solid tumors like pancreatic, colorectal, and soft-tissue sarcoma. The study enrolled 164 adults and measured how well the combo sh…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New combo attack on liver tumors shows promise for Tough-to-Treat cancer
Disease control CompletedThis phase 2 trial tested a three-part treatment for people with colorectal cancer that spread to the liver and stopped responding to standard treatments. The approach combines two minimally invasive procedures (TACE and HAIC) with the targeted drug regorafenib. The goal was to s…
Phase: PHASE2 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Priming tumors to unlock Immunotherapy's power
Disease control CompletedThis study tested a two-step approach for people with metastatic colorectal cancer that doesn't respond well to standard treatments. First, patients received a drug called temozolomide to make their tumors more genetically unstable. Then, they received the immunotherapy drug pemb…
Phase: PHASE2 • Sponsor: IFOM ETS - The AIRC Institute of Molecular Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Herbal formula shows promise in preventing polyp return
Disease control CompletedThis study tested a traditional Chinese medicine formula called modified Si Ni San in 32 adults who had colorectal polyps removed. The goal was to see if the herbal treatment could improve gut bacteria balance and reduce inflammation better than standard probiotics. Results may h…
Phase: NA • Sponsor: Xi'an Hospital of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New combo tackles tough colorectal cancer in small trial
Disease control CompletedThis study tested a combination of two treatments (regorafenib and FOLFIRINOX) in 13 people with a type of advanced colorectal cancer that has a specific gene change (RAS mutation). The main goal was to see if the combination was safe and tolerable. The study also looked at how l…
Phase: PHASE1, PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
CRISPR-Engineered immune cells take on stomach and colon cancers
Disease control CompletedThis trial tested a new approach for people with advanced gastrointestinal cancers that had stopped responding to standard treatments. Doctors removed immune cells from patients' tumors, used CRISPR gene editing to disable a gene called CISH, and then infused the modified cells b…
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Heated chemo drug tested for abdominal cancer spread
Disease control CompletedThis early-stage trial tested the safety and tolerability of a chemotherapy drug called raltitrexed when given as a heated solution directly into the abdomen (HIPEC) in 30 patients with colorectal cancer. The goal was to find the highest safe dose and understand how the drug beha…
Phase: PHASE1 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Parasite protein injection aims to tame Crohn's Flare-Ups
Disease control CompletedThis phase 2 trial tested the safety of P28GST, a protein from a parasite, in 10 adults with moderate Crohn's disease. Participants received three injections over three months. The goal was to see if the protein could safely control inflammation, especially after intestinal surge…
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Pressurized oxygen may heal radiation damage in cancer survivors
Disease control CompletedThis study tested whether hyperbaric oxygen therapy (HBOT) can help heal severe tissue damage caused by past radiation treatment. 39 adults who had radiotherapy and developed serious radiation injuries received HBOT sessions in a pressurized chamber while breathing pure oxygen. T…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Precision proton beam aims to spare healthy tissue in anal cancer treatment
Disease control CompletedThis pilot study tested a newer, more precise form of proton radiation called pencil beam scanning, given alongside standard chemotherapy drugs (5-FU and mitomycin-C), for people with anal cancer. The goal was to see if this combination is practical and might cause fewer skin sid…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for cancer patients: drug may prevent Chemo-Induced bleeding risk
Disease control CompletedThis study tested a drug called romiplostim in 165 adults with gastrointestinal, pancreatic, or colorectal cancer who were receiving chemotherapy. The goal was to see if romiplostim could prevent low platelet counts (thrombocytopenia) that often force doctors to delay or reduce c…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Which surgery works best for hirschsprung disease? new study compares swenson and soave techniques
Disease control CompletedThis study looked at 20 children with Hirschsprung disease, a condition where part of the bowel lacks nerve cells, causing severe constipation. Researchers compared two surgical methods—Swenson and Soave—to see which one had shorter operation time and better daily bowel movements…
Phase: NA • Sponsor: Ahmed Aouf • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a prebiotic soothe ulcerative colitis?
Disease control CompletedThis study tested whether a prebiotic called 2'-fucosyllactose can help people with mild-to-moderate ulcerative colitis. 38 adults took the prebiotic or a placebo for four weeks, then switched. Researchers measured symptoms, gut bacteria, and inflammation markers. The goal was to…
Phase: NA • Sponsor: Royal Berkshire NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Immunotherapy combo shows promise in Hard-to-Treat colorectal cancer
Disease control CompletedThis phase 2 trial tested whether adding the immunotherapy drug nivolumab to standard chemotherapy could help people with a specific type of metastatic colorectal cancer (MSS/pMMR). Eighty participants received either the combination or chemotherapy alone. The main goal was to se…
Phase: PHASE2 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Immunotherapy drug shows promise before colon cancer surgery
Disease control CompletedThis study tested the drug tislelizumab given before surgery in 33 people with early-stage colorectal cancer that has specific genetic changes (MSI-H or dMMR). The goal was to see if the drug could shrink or eliminate tumors before surgical removal. The trial has completed, and r…
Phase: PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo shows promise for Hard-to-Treat colon cancer
Disease control CompletedThis early-phase study tested a combination of two drugs, regorafenib and nivolumab, in 52 people with advanced colorectal cancer that had stopped responding to other treatments. The goal was to find the safest dose and see if the combination could help control the cancer. The st…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis phase II trial tested a combination of three drugs—TAS-102, irinotecan, and bevacizumab—in 42 people with advanced colorectal cancer that had spread or couldn't be removed. The goal was to see if this mix could slow tumor growth better than standard treatments. Participants …
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Aspirin and diet may fight cancer return
Disease control CompletedThis study looked at whether taking daily aspirin and vitamin D, along with exercise and a low-fat diet, could help prevent colorectal cancer from returning in 16 patients who had no visible cancer but still had signs of cancer DNA in their blood. The goal was to see if these lif…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New antibody combo shows promise against Hard-to-Treat colorectal cancer
Disease control CompletedThis phase II trial tested two different drug combinations in 240 people with advanced HER2-positive colorectal cancer that had spread and could not be removed by surgery. One group received the antibodies trastuzumab and pertuzumab, while the other received cetuximab (an antibod…
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
App-Based monitoring shows promise for IBD patients
Disease control CompletedThis study tested a web-based telemonitoring system called TECCU for people with moderate-to-severe inflammatory bowel disease (Crohn's disease or ulcerative colitis). 290 participants in Spain were randomly assigned to use the app or receive usual care. The goal was to see if th…
Phase: NA • Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo tackles tough colorectal cancer
Disease control CompletedThis phase 2 trial tested whether combining two drugs, sorafenib and irinotecan, works better than either drug alone in people with advanced colorectal cancer that has a KRAS mutation and has stopped responding to all standard treatments. The study enrolled 173 participants acros…
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cocktail shows promise against spread colon cancer
Disease control CompletedThis study tested a combination of the targeted drug cetuximab with a strong chemotherapy cocktail (FOLFIRINOX) as a first treatment for people whose colorectal cancer had spread and could not be removed by surgery. The goal was to see if this mix could shrink tumors better than …
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New device combo for liver chemotherapy shows promise in small trial
Disease control CompletedThis study tested whether a Medtronic pump and Codman catheter can safely deliver chemotherapy directly to the liver in 35 people with colorectal cancer or bile duct cancer that spread to the liver. The main goal was to check safety, including liver side effects and need for sten…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug SHR-A1811 targets HER2-Positive cancers in early trial
Disease control CompletedThis early-phase study tested a new drug called SHR-A1811 in 101 people with advanced stomach or colorectal cancers that have a specific protein called HER2. The main goals were to check the drug's safety, find the best dose, and see early signs of tumor shrinkage. Participants h…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo tackles tough colorectal cancer in early trial
Disease control CompletedThis study tested a combination of two drugs, sorafenib and irinotecan, in 64 adults with metastatic colorectal cancer that has a K-RAS mutation and has progressed after prior treatment. The goal was to see if the combination could control the disease and to check for side effect…
Phase: PHASE1, PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo therapy shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis study tested a combination of two drugs, lenvatinib and pembrolizumab, against the usual treatments for people with advanced colorectal cancer that had spread and stopped responding to prior therapy. About 563 adults took part. The goal was to see if the new combo helped peo…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can High-Dose chemo make liver tumors operable?
Disease control CompletedThis study tested whether more intense chemotherapy combinations could shrink liver tumors in people with colorectal cancer that cannot be fully removed by surgery. 124 participants received either standard two-drug chemo or one of three stronger regimens. The goal was to see if …
Phase: PHASE2, PHASE3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a sedative shield elderly lungs during cancer surgery?
Disease control CompletedThis study looked at whether the drug dexmedetomidine, given during laparoscopic surgery for rectal or sigmoid colon cancer, can protect the lungs of patients aged 60 and older. The trial included 64 participants and measured oxygen levels and other breathing indicators. The goal…
Phase: NA • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
First human trial of BI 765049 combo aims to fight hard-to-treat cancers
Disease control CompletedThis early-phase study tests two experimental drugs, BI 765049 and ezabenlimab, in adults with advanced solid tumors like colorectal, lung, and pancreatic cancer. The main goal is to find the highest safe dose of BI 765049 alone and in combination with ezabenlimab. Participants r…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Elderly cancer patients may benefit from geriatric support
Disease control CompletedThis study looked at whether a special care plan led by a geriatrician and a nurse could improve survival and quality of life for older adults (70+) with advanced cancer. 792 patients with breast, colorectal, lung, prostate, bladder, ovarian cancer, or lymphoma took part. The app…
Phase: NA • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New robotic surgery technique aims to ease recovery for rectal cancer patients
Disease control CompletedThis study tested a new robotic surgery method called natural orifice specimen extraction surgery (NOSES) for middle rectal cancer. In this approach, the removed tumor is taken out through the anus instead of a large abdominal cut. The study involved 150 patients and compared NOS…
Phase: NA • Sponsor: Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can an ultrasound predict who can skip surgery for rectal cancer?
Diagnosis CompletedThis study tested whether a special ultrasound technique (D-CEUS) can predict how well rectal cancer responds to chemotherapy and radiation. The goal is to identify good responders who might avoid major surgery and instead have a less invasive procedure. Only 2 people took part, …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
AI eye on your colon: can software spot polyps better?
Diagnosis CompletedThis study tests whether a software called ColoMaia II can help doctors find abnormal growths (polyps) in the colon during a routine colonoscopy. About 600 adults aged 40 to 80 having a screening or diagnostic colonoscopy will be randomly assigned to have the procedure with or wi…
Phase: NA • Sponsor: MAIA Labs s.r.o. • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New imaging agent targets LRRC15 to sharpen cancer diagnosis
Diagnosis CompletedThis study tests a special SPECT imaging agent that seeks out a protein called LRRC15, found on many aggressive cancers like pancreatic, breast, lung, and brain tumors. The goal is to see if this scan can help doctors diagnose and stage these cancers more accurately. Healthy volu…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Blood test may spot appendicitis faster, study finds
Diagnosis CompletedThis study looked at whether measuring a protein called calprotectin in the blood can help diagnose acute appendicitis. Researchers compared 74 patients with abdominal pain, some with confirmed appendicitis and others with non-specific pain. They measured calprotectin levels and …
Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:08 UTC
-
AI-Powered Low-Radiation CT scans could transform emergency diagnosis
Diagnosis CompletedThis study tested whether a low-dose CT scan, enhanced with deep learning image reconstruction, can diagnose acute abdominal conditions as accurately as a standard CT scan. 246 adults with abdominal pain received both scans, and the low-dose version used less than 30% of the usua…
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New light on colonoscopy: can enhanced imaging spot more polyps?
Diagnosis CompletedThis study tested whether a special light technology (enhanced white light endoscopy) helps doctors find more precancerous growths in the colon compared to standard colonoscopy. Over 800 adults aged 45 to 85 undergoing colonoscopy took part. The goal was to see if the enhanced li…
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:39 UTC
-
New radioactive tracer aims to spot colorectal cancer more clearly
Diagnosis CompletedThis early-phase trial tested a radioactive tracer called 68Ga-NODAGA-SNA009 in 12 people with colorectal cancer. The tracer targets a protein (GPA33) found on cancer cells and is used with PET scans to see where the cancer is in the body. The main goals were to check safety and …
Phase: EARLY_PHASE1 • Sponsor: SmartNuclide Biopharma • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
AI takes on colon cancer: can a computer beat the doctor at spotting dangerous polyps?
Diagnosis CompletedThis study tested whether an artificial intelligence system called CAD EYE can accurately predict if colon polyps are cancerous during a screening colonoscopy. Researchers compared the AI's predictions to the doctor's judgment and the final lab results. The goal is to see if AI c…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Dogs on the scent: can they sniff out cancer?
Diagnosis CompletedThis study tested whether specially trained dogs can identify breast, lung, prostate, or colorectal cancer by sniffing breath samples collected on masks. Over 1,300 people provided breath samples before their regular cancer screening or biopsy. The dogs' results were compared to …
Sponsor: SpotitEarly • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Pilot study pits cologuard against FIT for colon cancer screening in younger adults
Diagnosis CompletedThis pilot study compared two stool-based tests—Cologuard and the fecal immunochemical test (FIT)—for colorectal cancer screening in adults aged 45-49. Researchers mailed the tests to eligible participants and tracked how many completed screening, had abnormal results, and follow…
Phase: NA • Sponsor: University of California, San Diego • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New digital scope could help rectal cancer patients avoid surgery
Diagnosis CompletedThis study tested a new digital scope called LUMENEYE to see if it can better measure how much a rectal tumor has shrunk after chemotherapy and radiation. 82 patients who were good candidates for organ preservation were included. The goal was to see if the scope could help doctor…
Sponsor: Bordeaux Colorectal Institute Academy • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Which test spots colon leaks best? new study compares CT and endoscopy
Diagnosis CompletedThis study looked at 416 people who had left-sided colon surgery. A few days after surgery, each person got both a CT scan and an endoscopy to check for leaks where the colon was reconnected. The goal was to see which test is more accurate at finding these leaks. Results help doc…
Sponsor: Spital Limmattal Schlieren • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Blood test shows promise for anal cancer screening
Diagnosis CompletedThis study tested a simple blood test to screen for anal dysplasia, a precancerous condition linked to HPV. Researchers enrolled 104 people with past or current anal HPV, plus some healthy controls. The goal was to see if the blood test could detect and classify anal dysplasia wi…
Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
AI boosts colonoscopy accuracy for lynch syndrome patients?
Diagnosis CompletedThis study tested whether using artificial intelligence (AI) during colonoscopy helps find more polyps in people with Lynch syndrome, a genetic condition that raises colon cancer risk. One hundred participants each had two colonoscopies back-to-back, with the second using either …
Phase: NA • Sponsor: Sheba Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
AI helps doctors spot cancerous polyps during colonoscopy
Diagnosis CompletedThis study tested an artificial intelligence (AI) tool that helps doctors diagnose colorectal polyps during a colonoscopy. The AI analyzes images from a special high-magnification endoscope to predict whether a polyp is cancerous or not. The goal is to improve accuracy and reduce…
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
New test spots stray cancer cells that standard methods miss
Diagnosis CompletedThis study looked at a new test called OSNA to find free cancer cells in the belly fluid of 108 people with stomach or colon cancer who had no visible spread. The goal was to see if OSNA could detect cancer cells better than the usual lab method. If successful, this could help do…
Sponsor: University of Campania Luigi Vanvitelli • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Sound waves may spot nerve harm in cancer patients
Diagnosis CompletedThis pilot study tested whether ultrasound can detect nerve damage caused by the chemotherapy drug oxaliplatin in people with gastrointestinal cancer. Twenty participants who had or were receiving oxaliplatin and had symptoms of nerve damage underwent nerve ultrasounds, skin biop…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
3D camera could sharpen colonoscopy accuracy
Diagnosis CompletedThis completed trial tested whether a 3D imaging device helps doctors more accurately classify colon polyps and adenomas during colonoscopy compared to standard 2D imaging. 460 adults with colorectal polyps were randomly assigned to either 3D or 2D imaging before polyp removal. T…
Phase: NA • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Laser ruler for colon polyps could sharpen cancer risk checks
Diagnosis CompletedThis study tested a new laser-based device (AccuMeasure) to measure the size of colon polyps during a colonoscopy. Accurate polyp size is important because it helps doctors decide how often patients need follow-up screenings to prevent colorectal cancer. The study involved 138 ad…
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Which test is best for colon cancer screening in High-Risk families?
Diagnosis CompletedThis study looked at three screening methods—colonoscopy, colon capsule endoscopy, and a fecal immunochemical test (FIT)—to detect colorectal cancer or advanced growths in people aged 45 and older who have a first-degree relative with colorectal cancer. The goal was to see if the…
Sponsor: Hôpital Edouard Herriot • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
AI boosts polyp detection in colon cancer screening Follow-Up
Diagnosis CompletedThis study tested whether an AI tool (GI Genius) helps doctors find more polyps during colonoscopy in people aged 50-74 who had a previous polyp. Over 1,100 participants were randomly assigned to either AI-assisted or standard colonoscopy. The main goal was to see if AI increases…
Phase: NA • Sponsor: Fondazione Poliambulanza Istituto Ospedaliero • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Could a simple blood test boost colon cancer screening in appalachia?
Diagnosis CompletedThis study looked at whether offering a blood test for colorectal cancer screening would be accepted by average-risk patients in Appalachian outpatient clinics. Over 200 participants were given the option of a standard screening method or a blood-based test called Shield. The goa…
Phase: NA • Sponsor: Ballad Health • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Doctor's checklist may catch more colon cancers early
Prevention CompletedThis study tests whether giving general practitioners a list of patients who have not completed colorectal cancer screening encourages those patients to get screened. Over 48,000 patients aged 50-74 are involved, and their doctors either receive the list or do not. The goal is to…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Simple nudges boost colon cancer screening rates
Prevention CompletedThis study tested whether personalized reminders (like texts or emails) could encourage more people to return their at-home stool test kits for colon cancer screening. Over 2,100 adults aged 45 to 75 who had not yet returned their kit took part. The goal was to see if these gentl…
Phase: NA • Sponsor: Laura Feemster • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Diet and weight loss may cut colon cancer risk, study finds
Prevention CompletedThis study looked at whether a Mediterranean diet, weight loss, or both could lower colorectal cancer risk in 180 obese African Americans aged 45-75. Participants followed one of four plans for six months, and researchers measured changes in bile acids, gut bacteria, and cell act…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
At-home test kits mailed to thousands could catch colon cancer early
Prevention CompletedThis study looked at whether mailing free stool tests (FIT kits) to people's homes could increase colorectal cancer screening rates. Over 4,300 adults aged 45-75 who were at average risk took part. The goal was to make screening easier for those who might otherwise skip it, espec…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Can a simple nudge get cancer spouses screened? study says maybe.
Prevention CompletedThis study looked at whether giving extra help and information to spouses of colorectal cancer patients could get them to complete a simple at-home screening test (FIT). About 60 people took part. The goal was to find out what stops them from screening and if a tailored approach …
Phase: NA • Sponsor: National University Health System, Singapore • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Heartburn drug and aspirin combo may help prevent colon polyps
Prevention CompletedThis study looked at whether taking omeprazole (a heartburn drug) and low-dose aspirin together could help prevent colorectal polyps in people at high risk. Twenty-one adults with a history of multiple polyps took both pills daily for 25-45 days. Researchers collected tissue samp…
Phase: EARLY_PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Colonoscopy vs. stool test: which screens better for colon cancer?
Prevention CompletedThis phase 3 trial compared colonoscopy with annual fecal occult blood tests for colorectal cancer screening in nearly 5,000 healthy adults aged 50-69. The goal was to see which method finds more early tumors and has a better balance of benefits and harms. Participants were rando…
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Rural screening program aims to catch colon cancer early
Prevention CompletedThis study tested a community-based program to encourage colorectal cancer screening in rural China. Over 20,000 adults aged 45-70 took part. The goal was to increase the number of people who complete a colonoscopy after initial risk assessment and stool tests, since early detect…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Magnesium may shield against colon cancer in genetically At-Risk individuals
Prevention CompletedThis study tested whether taking magnesium supplements could reduce the risk of colorectal cancer in people with a specific genetic makeup. Researchers gave 250 participants either magnesium or a placebo for 12 weeks and measured changes in colon tissue markers linked to cancer d…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Could a Two-Drug pain block ease recovery after colon cancer surgery?
Symptom relief CompletedThis trial compares two approaches to a nerve block (TAP block) for pain after colorectal cancer surgery. One group receives the standard numbing drug bupivacaine, while the other gets bupivacaine plus dexmedetomidine, a drug that may extend pain relief. The study measures pain s…
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Less antibiotics after appendix surgery may cut side effects
Symptom relief CompletedThis study looked at whether giving fewer antibiotics after appendicitis surgery could lower the risk of antibiotic side effects without compromising patient safety. Over 650 adults who had surgery for simple or complicated appendicitis took part. The goal was to find the right b…
Phase: NA • Sponsor: Denver Health and Hospital Authority • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New recovery plan may get kids home faster after bowel surgery
Symptom relief CompletedThis study tested a 21-step enhanced recovery protocol for children aged 10-18 undergoing elective gastrointestinal surgery. The protocol included things like shorter fasting times, early eating and moving, and less use of opioids. The goal was to see if it could shorten hospital…
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Could a simple drug combo cut morphine use after colon surgery?
Symptom relief CompletedThis study looked at whether adding the drug nefopam to standard pain relief (morphine and paracetamol) can reduce the amount of morphine needed after major colon surgery. 80 adults having planned surgery for colon cancer or diverticulosis took part. The main goal was to measure …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Warm gas during keyhole surgery may cut pain and opioid use
Symptom relief CompletedThis study tested whether using warm, humidified carbon dioxide gas during low-pressure laparoscopic colorectal surgery reduces pain 24 hours after the procedure. 148 adults having surgery for colon or rectal tumors (benign or malignant) took part. One group received warm, moist …
Phase: NA • Sponsor: Bordeaux Colorectal Institute Academy • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New drug M701 aims to stop Cancer-Related fluid buildup without drains
Symptom relief CompletedThis study tested a drug called M701, given directly into the belly, combined with standard cancer therapy, for people with malignant ascites (fluid buildup) from stomach, colon, or ovarian cancer. The goal was to see if M701 could delay the need for fluid drainage and improve su…
Phase: PHASE2 • Sponsor: Wuhan YZY Biopharma Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Bridge device for stoma: does it help or hinder?
Symptom relief CompletedThis study looked at whether placing a bridge device during loop ileostomy creation reduces complications like infections or stoma problems. 166 adults having elective colorectal surgery took part. The goal was to see if the device improves outcomes or just adds difficulty to car…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Talking it out: could CBT ease anxiety and depression in IBD patients?
Symptom relief CompletedThis study tests whether cognitive behavioral therapy (CBT) can reduce anxiety and depression in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis). Participants receive either psychologist-led or self-administered CBT over 8 weeks. The goal is to see …
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Beauty treatments ease cancer pain and anxiety, study finds
Symptom relief CompletedThis study tested whether professional socio-aesthetics (specialized beauty and well-being care) can improve quality of life, reduce pain, and ease anxiety in adults undergoing chemotherapy for lung, breast, colon, or prostate cancer. 400 participants were randomly assigned to re…
Phase: NA • Sponsor: Centre Hospitalier de Valence • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Exercise and creatine combo may restore strength in cancer survivors
Symptom relief CompletedMany colorectal cancer survivors lose muscle mass and strength after chemotherapy. This study tested whether adding creatine supplements to a 10-week resistance training program could help. Twenty-seven survivors participated, comparing those who took creatine with those who only…
Phase: NA • Sponsor: University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Numbing injection may cut appendicitis pain before emergency surgery
Symptom relief CompletedThis study tested whether a numbing injection into the abdominal wall muscles (called a TAP block) can reduce pain for people with acute appendicitis waiting for emergency surgery. 105 adults in the emergency department received the block, and researchers measured how much pain m…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New digital tool aims to boost Pre-Surgery fitness in seniors with colon cancer
Symptom relief CompletedThis study tested a web app called PrehabPal designed to help frail adults aged 65 and older prepare for colon cancer surgery. The app creates a personalized prehabilitation program and offers coaching. Researchers compared it to standard written instructions in 132 participants …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Ear zap device cuts opioid need after major surgery
Symptom relief CompletedThis study tested a small, disposable device that gently stimulates nerves in the ear to see if it could reduce the amount of strong painkillers (opioids) needed after open abdominal or pelvic surgery. 286 adults who had surgery for cancer or a liver transplant took part. The goa…
Phase: NA • Sponsor: Jacques E. Chelly • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Hypnosis eases pain and anxiety during rectal cancer procedure, study finds
Symptom relief CompletedThis study tested whether a self-regulation hypnotic intervention could help reduce pain and anxiety during brachytherapy for rectal cancer. Fifty-two adults were randomly assigned to receive either hypnosis training or standard care with pain and anxiety medication. Researchers …
Phase: NA • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New drug targets wasting syndrome in cancer patients
Symptom relief CompletedThis study tested an investigational drug called ponsegromab in 187 adults with lung, pancreatic, or colorectal cancer who also had cachexia—a condition causing severe weight loss, loss of appetite, and fatigue. The goal was to see if ponsegromab could help patients gain weight a…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Silkworm pupa tablets tested to fight frailty after cancer surgery
Symptom relief CompletedThis study tested whether silkworm pupa tablets can improve nutrition and reduce frailty in people who had surgery for stomach, colorectal, esophageal, or pancreatic cancer. 120 participants took the tablets for 3 months. Researchers measured weight, frailty, muscle mass, and qua…
Phase: NA • Sponsor: Xiaosun Liu, MD • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Can simple muscle exercises fix post-surgery bowel chaos?
Symptom relief CompletedThis study tested whether the Paula Method of muscle exercises can help people who have bowel control problems after rectal cancer surgery. 62 adults who had surgery and still had symptoms took part. The exercises aim to strengthen muscles naturally without drugs or surgery.
Phase: NA • Sponsor: Hadassah Medical Organization • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Fiber supplement may ease bowel troubles after rectal cancer surgery
Symptom relief CompletedThis study tested whether psyllium husk, a type of fiber supplement, can reduce bowel symptoms and improve quality of life in people who had rectal cancer surgery. 24 participants who had ongoing bowel issues after surgery took psyllium husk. The goal was to see if it helps with …
Phase: NA • Sponsor: Sykehuset Telemark • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can an online wellness program ease anxiety in chronic disease?
Symptom relief CompletedThis study tested a 12-week online mind-body program for adults with chronic conditions like heart failure, cancer, and liver disease. The program included mindful movement, meditation, breathwork, and coping skills. Researchers measured changes in anxiety, depression, fatigue, a…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New stent technique may replace ileostomy for rectal cancer patients
Symptom relief CompletedThis study tested whether a temporary stent placed inside the bowel could replace a traditional ileostomy (a bag outside the body) after rectal cancer surgery. 570 patients at high risk for leaks were randomly assigned to either the stent or ileostomy. The goal was to see if the …
Phase: NA • Sponsor: Sir Run Run Shaw Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Which pain block works best for kids after appendix removal?
Symptom relief CompletedThis study compared two types of nerve blocks—erector spinae plane (ESP) and quadratus lumborum (QL)—to see which provides better pain relief after appendix surgery in children aged 3-13. Sixty children received one of the blocks along with general anesthesia. Researchers measure…
Phase: NA • Sponsor: Zeycan Kahya • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Pre-Surgery workout may speed up recovery for colorectal cancer patients
Symptom relief CompletedThis study looked at whether doing special exercises before colorectal cancer surgery (called prehabilitation) helps patients recover better compared to standard care. Over 700 adults scheduled for surgery took part. The main goal was to see if the exercise group had better physi…
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Ice packs may cut opioid use after Kids' appendix surgery
Symptom relief CompletedThis study tested whether using a cold therapy device on the belly after appendix removal helps control pain in children ages 7 and older. Half the kids got the cold pack plus usual care, the other half got usual care alone. Researchers measured pain scores, morphine use, and hos…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Nurse phone calls may ease chemo side effects and anxiety
Symptom relief CompletedThis study tested whether two nurse phone calls during the first three cycles of chemotherapy could improve the emotional state and quality of life of patients with breast, colon, or rectal cancer. 274 patients were randomly assigned to receive either standard care or standard ca…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New online program aims to ease cancer treatment side effects
Symptom relief CompletedThis study tested a web-based support program for people with colorectal cancer undergoing treatment. The program provided information and tips on physical, emotional, and daily-life challenges. Researchers measured whether it helped reduce symptoms and improve quality of life co…
Phase: NA • Sponsor: Ilknur Yazicioglu • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New study shows promise in easing cancer caregiver anxiety
Symptom relief CompletedThis study tested whether an education and support program can help family caregivers of cancer patients feel more confident and less anxious. About 484 caregivers and patients took part. Researchers compared different types of support to see which worked best.
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could a probiotic soothe PTSD? new study tests Gut-Brain link in veterans
Symptom relief CompletedThis study tested whether a probiotic called Lactobacillus rhamnosus GG can reduce inflammation and PTSD symptoms in veterans. Researchers enrolled 383 veterans with PTSD and gut issues, giving them either the probiotic or a placebo. The goal was to see if calming inflammation in…
Phase: PHASE2 • Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Smaller tools, less pain? new study tests 'low-impact' appendix surgery
Symptom relief CompletedThis study tested a newer, gentler type of keyhole surgery for removing the appendix. It uses lower gas pressure and smaller instruments than standard laparoscopy. Fifty adults with uncomplicated appendicitis took part, and the researchers measured their pain, recovery time, and …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Mindfulness may ease stress for liver patients
Symptom relief CompletedThis study looked at whether mindfulness exercises can lower stress and improve communication between patients with liver disease and their doctors. 56 adults took part, answering surveys about their stress, anxiety, and how well they felt they could share decisions with their he…
Sponsor: Methodist Health System • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New pill could ease carcinoid syndrome Flare-Ups
Symptom relief CompletedThis Phase 2 trial tested paltusotine, an oral drug, in 36 adults with carcinoid syndrome. The study looked at safety and how the body processes the drug at different doses. Participants were randomly assigned to 40 mg or 80 mg daily, with dose adjustments allowed. The goal is to…
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New study examines pain and adherence in patients switching to concentrated adalimumab
Symptom relief CompletedThis study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who switched from a standard to a higher-concentration form of adalimumab (AVT-02). Researchers measured injection site pain and how well patients stuck with their treatment over 180 days…
Sponsor: Jamp Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Chewing gum: the surprising Post-Surgery remedy?
Symptom relief CompletedThis study looked at whether chewing gum after colorectal surgery can help reduce nausea, vomiting, and get the bowels working again sooner. 84 adults who had laparoscopic colorectal surgery took part. The idea is that chewing tricks the body into thinking it's eating, which may …
Phase: NA • Sponsor: Cukurova University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Which pill do patients prefer? study compares two chemo options for colorectal cancer
Symptom relief CompletedThis study looked at two oral chemotherapy drugs, Xeloda and UFT with folinic acid, in 89 people with advanced or metastatic colorectal cancer. The main goal was to see which treatment patients preferred after trying both. The study also checked how safe each drug was. Results he…
Phase: PHASE3 • Sponsor: Centre Oscar Lambret • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Digital coaching eases cancer treatment struggles
Symptom relief CompletedThis study tested an online educational program for cancer patients receiving chemotherapy. The program included video sessions, peer discussions, and digital materials to help with symptom management and emotional coping. Researchers compared 212 patients who used the program to…
Phase: NA • Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a bile acid pill ease ulcerative colitis?
Symptom relief CompletedThis early-phase study tested whether TUDCA, a bile acid supplement, is safe and can reduce stress in gut cells of people with active ulcerative colitis. Fourteen adults took TUDCA for 6 weeks while researchers measured changes in cell stress markers from colon biopsies. The goal…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a plant-based supplement calm chemo-related diarrhea?
Symptom relief CompletedThis phase II trial tested a concentrated plant dietary supplement (made from foods like taro, rice, and carrots) in 30 people with gastrointestinal cancers who had diarrhea from chemotherapy. Participants received the supplement alongside standard anti-diarrheal treatment. The g…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Phone therapy eases cancer Survivors' distress in rural areas
Symptom relief CompletedThis study tested a stepped-care telehealth program for cancer survivors living in rural areas who experience anxiety, depression, or sleep problems. Participants received either low-intensity check-ins or high-intensity phone therapy with a licensed therapist, depending on sympt…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New rehab program aims to ease life after colorectal cancer
Symptom relief CompletedThis study tested a personalized rehabilitation program for 150 adults who finished treatment for colorectal cancer. The program connects patients with specialists like physiotherapists, dietitians, and psychologists based on their individual needs. The goal was to improve qualit…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Virtual rehab may offer same benefits as In-Person for advanced cancer patients
Symptom relief CompletedThis study tested whether group-based cancer rehabilitation could work when done virtually instead of in person for people with advanced breast or colorectal cancer. 111 participants were offered either in-person or online sessions to see which was more practical and acceptable. …
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Nerve blocks may offer better pain relief for appendicitis patients in the ER
Symptom relief CompletedThis study compared two types of nerve blocks (TAP and ESPB) to standard pain medication (tramadol) for people with acute appendicitis in the emergency department. The goal was to see if these blocks could reduce pain before surgery and lower the need for opioids. The trial inclu…
Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Gentler gas pressure may ease Kids' pain after appendix surgery
Symptom relief CompletedThis study looked at 250 children having laparoscopic surgery for appendicitis. It compared using low versus medium gas pressure in the belly during the operation to see if it affects pain the next day. The goal is to find ways to make children more comfortable after surgery.
Phase: NA • Sponsor: University Children's Hospital, Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can free legal services ease the burden of colorectal cancer?
Symptom relief CompletedThis pilot study tested whether offering free, personalized legal services to people with advanced colorectal cancer could help reduce stress, financial worries, and improve quality of life. Twenty participants received help from a nonprofit legal organization for six months. Res…
Phase: EARLY_PHASE1 • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Common supplement may shield cancer patients from nerve pain
Symptom relief CompletedThis study tested whether taking N-Acetylcysteine before chemotherapy could reduce nerve damage in colorectal cancer patients receiving oxaliplatin. 46 participants received either N-Acetylcysteine or a placebo before each chemo session. The goal was to see if the supplement coul…
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Which nerve block eases Post-Surgery pain best?
Symptom relief CompletedThis study compared two types of nerve blocks (erector spinae plane block vs. transversus abdominis plane block) for pain relief after laparoscopic appendix removal. 72 adults aged 18-50 participated. The goal was to see which block provides better pain control and fewer complica…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
App aims to boost cancer patients' well-being at home
Symptom relief CompletedThis completed trial tested a web-based remote monitoring platform called CONTINUUM+ CONNECT in 411 adults with metastatic breast, lung, colorectal, or prostate cancer. Patients used the platform to report symptoms and receive alerts, aiming to improve their physical health and q…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New bladder training cuts Post-Surgery catheter woes
Symptom relief CompletedThis study tested a bladder training method called ICCAUT in 400 people who had rectal cancer surgery. The training involves clamping the urinary tube and practicing urinating before the tube is removed. The goal was to see if this reduces the need for a new catheter or incomplet…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Iron pill shows promise for anemia after colon cancer surgery
Symptom relief CompletedThis study tested whether an oral iron pill (ferric maltol) can improve anemia in 40 adults after colorectal cancer surgery, compared to standard care. The main goal was to see if a larger study is possible, while also checking blood iron levels. The approach is simple and aims t…
Phase: PHASE3 • Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could breast cancer survivors face higher colon cancer risk?
Knowledge-focused CompletedThis study investigates whether women who have completed breast cancer treatment have a higher chance of developing colorectal polyps or colon cancer. Researchers will perform screening colonoscopies in 216 asymptomatic breast cancer survivors and check for abnormal growths. The …
Phase: NA • Sponsor: Haydarpasa Numune Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can a quick chat with a radiotherapy tech ease cancer patients' anxiety?
Knowledge-focused CompletedThis study looked at whether having a special consultation with a radiotherapy technician (called a manipulator) helps cancer patients feel more informed about their treatment. Researchers enrolled 308 adults with various cancers who were getting radiation therapy. They compared …
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Family talk could be key to preventing disease in Mexican-American communities
Knowledge-focused CompletedThis study examined how Mexican-American families discuss their risk for diabetes, heart disease, breast cancer, and colon cancer. Researchers interviewed 498 adults from Mexican-American households in Houston to understand how culture and family history influence health communic…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a simple activity tracker help cancer survivors move more?
Knowledge-focused CompletedThis study looked at whether using a physical activity screener, along with exercise coaching and self-monitoring, could help breast and colon cancer survivors become more active and spend less time sitting. Twenty survivors who had finished their main cancer treatment at least t…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can a simple weekly survey help close racial gaps in cancer care?
Knowledge-focused CompletedThis study tested whether a weekly electronic survey could help identify cancer treatment delays and racial differences. About 100 adults with newly diagnosed breast or colorectal cancer who hadn't started treatment yet filled out a short survey each week for 8 weeks. The goal wa…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Empty bladder may steady the target in rectal cancer radiation
Knowledge-focused CompletedThis study investigates whether having an empty bladder reduces movement of the mesorectum (tissue around the rectum) during radiotherapy for rectal cancer. About 50 adults with rectal cancer receive planning CT scans and weekly CBCT scans under both empty and full bladder condit…
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Scientists investigate gut-healing protein in Crohn's and colitis
Knowledge-focused CompletedThis study looked at how a protein called IL-22 binding protein (IL-22BP) affects gut healing in people with Crohn's disease or ulcerative colitis. Researchers compared samples from 52 patients and healthy volunteers to understand how IL-22BP is regulated during disease flares. T…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Appendicitis dilemma: survey reveals patient regret over treatment choice
Knowledge-focused CompletedThis completed study surveyed over 2,500 appendicitis patients to understand their satisfaction and regret after choosing either surgery or antibiotics. Researchers aim to use this information to design decision-support tools that help future patients make choices aligned with th…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Fit gut: study links exercise to healthier microbiome
Knowledge-focused CompletedThis study looks at how being physically fit changes the bacteria in your gut. Researchers will compare the gut microbes of 30 healthy men, from inactive to elite athletes, by testing their exercise capacity and analyzing stool samples. The goal is to find connections between fit…
Sponsor: University of Rennes 2 • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Gut bacteria may hold key to treating severe colitis
Knowledge-focused CompletedThis study investigates whether gut microorganisms and their byproducts play a role in triggering severe flare-ups of ulcerative colitis. Researchers will compare patients hospitalized with severe colitis to those with milder symptoms, analyzing stool and blood samples over three…
Phase: EARLY_PHASE1 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
CT scans could predict dangerous leaks after rectal cancer surgery
Knowledge-focused CompletedThis study looks at whether a narrowed inferior mesenteric artery (IMA) — seen on routine CT scans — is linked to a higher chance of anastomotic leakage after rectal cancer surgery. Anastomotic leakage is a serious complication where the surgical connection leaks. The study will …
Sponsor: Istanbul Saglik Bilimleri University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists uncover hidden electrical switch that fuels colorectal Cancer's spread
Knowledge-focused CompletedThis study investigates how differences in cell membrane voltage, caused by varying physical pressures inside a tumor, help colorectal cancer resist chemotherapy and evade the immune system. Using advanced lab models and tissue samples from 11 patients, researchers found that cel…
Sponsor: Ma Tianyi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can fiber be gentle? study tests tolerable doses for sensitive guts
Knowledge-focused CompletedThis study looked at how well people with self-reported fiber sensitivity tolerate different doses of soluble fiber. 141 adults took fiber or a placebo for 7 days, and researchers measured digestive symptoms and dropout rates. The goal was to find a dose that causes minimal disco…
Phase: NA • Sponsor: Danone Global Research & Innovation Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can PET/CT scans improve Follow-Up for anal cancer patients?
Knowledge-focused CompletedThis study followed 110 people with anal cancer to see if PET/CT scans can help doctors monitor the disease after initial treatment. Researchers tracked how long patients stayed cancer-free and measured metabolic activity in tumors. The goal is to find better ways to detect relap…
Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scientists create detailed map of appendix cells
Knowledge-focused CompletedThis study aimed to create a detailed map of the cells in the human appendix and understand their genetic activity. Researchers analyzed appendix tissue from 5 patients undergoing colon cancer surgery. The goal was to learn more about the appendix's role in the immune system and …
Sponsor: Bispebjerg Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists create detailed map of colon cells to unlock disease secrets
Knowledge-focused CompletedThis completed study took small tissue samples from the colons of 40 people during routine colonoscopies. Using advanced genetic techniques, researchers created a detailed map of the different cell types and their gene activity. The goal is to better understand how colon diseases…
Sponsor: Bispebjerg Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Blood test may predict chemo success in colorectal cancer
Knowledge-focused CompletedThis study looked at whether a new blood test called EPISPOT can predict how well chemotherapy works in people with metastatic colorectal cancer. Researchers measured circulating tumor cells in 168 patients before and during treatment. The goal was to see if early changes in thes…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Lynch syndrome patients share colonoscopy struggles in new survey
Knowledge-focused CompletedThis study surveyed 231 adults with Lynch syndrome, an inherited condition that raises bowel cancer risk. Researchers wanted to find out how many people follow the UK recommendation of a colonoscopy every two years, and what makes it harder or easier to keep up with these check-u…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Magnetic zaps to the spine: a new way to tame bowel troubles?
Knowledge-focused CompletedThis study looked at whether magnetic stimulation of nerves in the lower back can change how the colon moves. It included 30 people: healthy volunteers, and patients with constipation or fecal incontinence. The goal was to understand the effect, not to treat the condition.
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Large study reviews bleeding risks of common cancer drug in japanese patients
Knowledge-focused CompletedThis study looked at the safety of Bevacizumab-Pfizer Biosimilar, a drug used to treat colorectal cancer, by analyzing medical records from 1,000 patients in Japan. Researchers focused on side effects like bleeding, high blood pressure, and kidney problems. The goal was to unders…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Chatbot boosts cancer screening uptake in hong kong trial
Knowledge-focused CompletedThis study tested whether a theory-based chatbot could increase colorectal cancer screening rates. 500 adults aged 50-75 in Hong Kong were randomly assigned to receive either standard text reminders or a chatbot that provided personalized risk information and screening guidance. …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Massive study reveals hidden dangers of common steroid treatments
Knowledge-focused CompletedThis completed study looked at over 107,000 patients in Germany to understand the long-term side effects of systemic steroids (corticosteroids) used for conditions like asthma, COPD, and arthritis. Researchers compared patients who took steroids with those who did not, tracking r…
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Study reveals hidden toll of chemo on hands: grip strength and quality of life under the microscope
Knowledge-focused CompletedThis completed study looked at how nerve damage from the chemotherapy drug oxaliplatin affects hand function, grip strength, and quality of life in 103 colorectal cancer patients. Researchers measured hand and finger strength, dexterity, and daily living abilities using standard …
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Smart scans and DNA tests could revolutionize liver cancer care
Knowledge-focused CompletedThis study looked at whether combining detailed MRI scans with whole genome sequencing can help doctors choose the best treatment for people with liver cancer. Researchers studied 200 adults who were scheduled for liver surgery. The goal was to see if these advanced tests provide…
Sponsor: Perspectum • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
IBD patients at risk for eating disorders, study finds
Knowledge-focused CompletedThis study measured how often adults with inflammatory bowel disease (Crohn's disease or ulcerative colitis) show signs of eating disorders, including avoidant/restrictive food intake disorder (ARFID). Researchers used questionnaires to assess eating habits and nutritional status…
Sponsor: Federico II University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Could a simple nerve block shield kidneys during cancer surgery?
Knowledge-focused CompletedThis study looked at whether a nerve block called the erector spinae plane block can protect kidney function during laparoscopic colorectal cancer surgery. Sixty adults having this surgery were divided into two groups: one received the nerve block plus standard anesthesia, the ot…
Phase: NA • Sponsor: Kayseri City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Tiny tumor clusters may predict colon cancer outcomes
Knowledge-focused CompletedThis study looked at 30 colorectal cancer patients to see if tumor deposits (small clusters of cancer cells found near the main tumor) can help predict survival and whether the cancer spreads to other organs. Researchers tracked overall survival and the appearance of new metastas…
Sponsor: Minia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New scoring system aims to better predict ulcerative colitis outcomes
Knowledge-focused CompletedThis study tested a new scoring system called CAT-DESIRE to evaluate ulcerative colitis severity using colonoscopy images. Researchers reviewed images from 235 patients to see if the new score is reliable and can predict long-term outcomes. The goal is to provide a simple, accura…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New study finds best ways to get cancer survivors screened for colon cancer
Knowledge-focused CompletedThis study looked at the best ways to encourage childhood cancer survivors who are at high risk for colorectal cancer to get screened at the recommended age. Researchers tested different methods to see which helped more people complete a colonoscopy or stool-based test. The goal …
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Study reveals Real-World choices in treating complicated diverticulitis
Knowledge-focused CompletedThis study looked at how 208 patients with severe diverticulitis were treated at a Brussels hospital network between 2015 and 2024. Researchers wanted to see which treatments doctors chose, such as medication alone, drainage, or different types of surgery. The goal was to underst…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Blood test hunts hidden cancer after surgery
Knowledge-focused CompletedThis study looked for leftover cancer DNA in the blood of over 2,000 people who had surgery for stage II or III colorectal cancer. Participants did not receive any new treatment—they just gave blood samples over about 21 months. The goal was to find patients who might be eligible…
Sponsor: BioNTech SE • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Study reveals Long-Term career and school impacts of Early-Onset IBD
Knowledge-focused CompletedThis study looked at 343 adults who were diagnosed with inflammatory bowel disease (Crohn's disease or ulcerative colitis) before age 17. Researchers compared their employment rates and education levels to the general population to understand how the disease may affect long-term …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can a custom exercise program help black colon cancer survivors get moving?
Knowledge-focused CompletedThis study tested a physical activity program called PACE for African American colorectal cancer survivors. Researchers wanted to see if the program was practical and could increase steps and exercise. Twenty-one participants used Fitbits and watched videos to track their activit…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Simple blood test may predict Post-Surgery confusion in colorectal cancer patients
Knowledge-focused CompletedThis study looked at 590 colorectal cancer patients to develop a risk tool that predicts postoperative delirium—a common complication causing confusion and slower recovery. Researchers combined blood test results (including the TyG index) with patient subtypes to create a scoring…
Sponsor: LanZhou University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Step up against cancer: study links daily walks to better treatment outcomes
Knowledge-focused CompletedThis study looked at whether being more physically active, measured by daily steps, helps rectal cancer patients respond better to chemotherapy and radiation before surgery. About 120 participants wore smartwatches to track their steps, heart rate, and sleep. The goal was to see …
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
AI takes on cancer experts: who wins?
Knowledge-focused CompletedThis study looked at whether an AI computer program could suggest cancer treatments that match what experts recommend. Researchers reviewed medical records of 30 people with stomach, colon, or pancreatic cancer. They entered key details into the AI and compared its suggestions to…
Sponsor: Medizinische Hochschule Brandenburg Theodor Fontane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Blood tests and surveys may predict cancer treatment success
Knowledge-focused CompletedThis study followed 159 people with metastatic colorectal, pancreatic, biliary, or esophageal cancers who were starting a new line of therapy. Researchers collected blood samples (tumor markers and liquid biopsies) and patient-reported quality-of-life data to see if these could p…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Distance to hospital may delay Life-Saving chemo for colon cancer patients
Knowledge-focused CompletedThis study looked at 140 patients who had colon cancer surgery and chemotherapy at Rouen University Hospital. The goal was to see if living farther from the hospital caused a longer wait to start chemotherapy after surgery. The findings could help improve care for patients who li…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
What do patients really think about colon tests? small study aims to find out
Knowledge-focused CompletedThis completed study interviewed 12 patients waiting for either a colonoscopy or a colon capsule endoscopy. The goal was to understand what factors are most important to them when deciding between these two colon tests. Researchers used telephone interviews and analyzed the conve…
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can naming your feelings boost resilience in young cancer survivors?
Knowledge-focused CompletedThis completed study looked at how well young and middle-aged colorectal cancer survivors can identify and describe their specific emotions—a skill called emotional granularity—and whether that helps them build resilience. Researchers surveyed 242 survivors online and interviewed…
Sponsor: The Hong Kong Polytechnic University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Gut antibody study aims to unlock Crohn's secrets
Knowledge-focused CompletedThis study looked at antibodies in the intestines of 160 people: 80 with Crohn's disease, 40 with ulcerative colitis, and 40 without inflammatory bowel disease. Researchers took blood samples and intestinal biopsies to compare antibody levels in the gut versus the blood. The goal…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New study seeks better ways to diagnose and predict inflammatory bowel disease
Knowledge-focused CompletedThis study looked at 366 adults referred for suspected inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The goal was to find simple, non-invasive markers that can help doctors diagnose IBD more accurately and predict how the disease will progres…
Sponsor: University of Southern Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Gene study reveals clues about ulcerative colitis risk and drug effectiveness
Knowledge-focused CompletedThis study examined how differences in the BAFF gene might affect a person's risk of developing ulcerative colitis and how well they respond to the drug vedolizumab. Researchers analyzed genetic samples from 841 people with ulcerative colitis. The goal was to better understand th…
Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Researchers watch how IBD patients pick their vedolizumab shot or drip
Knowledge-focused CompletedThis study observed 165 people with inflammatory bowel disease (Crohn's or ulcerative colitis) in Poland who were already taking or starting vedolizumab. Researchers tracked whether patients chose intravenous or subcutaneous (under-the-skin) injections, and how long they stayed o…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can an app help your doctor know your family health risks?
Knowledge-focused CompletedThis study tested whether a family history app can help doctors collect and use information about patients' family health risks. Over 600 adults aged 30-69 took part. The goal was to see if the app leads to better screening and genetic referrals for conditions like cancer, heart …
Phase: NA • Sponsor: University of Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New biopsy method may predict cancer spread without surgery
Knowledge-focused CompletedThis study looked at 150 colorectal cancer patients to see if counting tumor buds in biopsy samples could predict whether cancer has spread to lymph nodes or other organs. Researchers used a special stain to find tumor buds and counted them in the densest area. They then used a c…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to define safety of common bowel cancer surgery
Knowledge-focused CompletedThis study involved 132 adults with colorectal cancer who had standard surgery (low anterior resection) and a temporary ileostomy (a stoma to divert waste). The goal was to measure major complications after surgery and create a single safety endpoint. This will help doctors compa…
Sponsor: SafeHeal Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New classification system may help guide treatment for colorectal cancer spread to liver
Knowledge-focused CompletedThis study tested a new classification system for people whose colorectal cancer has spread only to the liver. Researchers looked at survival rates and compared different patient groups to see if the system helps predict outcomes. The goal is to better identify which patients mig…
Sponsor: University Hospital, Linkoeping • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Joint pain from cancer drug measured in new study
Knowledge-focused CompletedThis completed study looked at how often joint pain occurs in 71 people with ovarian, colorectal, or lung cancer who were taking the drug bevacizumab. Participants filled out a questionnaire about their joint pain over 6 months. The goal was to better understand this side effect.
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study digs into why some young adults get advanced colon cancer
Knowledge-focused CompletedThis completed study looked back at medical records of 500 patients aged 50 or younger diagnosed with colorectal cancer or precancerous growths at a hospital in Shenzhen, China. Researchers compared those with early-stage disease to those with later-stage disease to identify fact…
Sponsor: Run-hua Li • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Rare leg injury during surgery: new study sheds light on hidden danger
Knowledge-focused CompletedThis study looked at 26 adults having colorectal (bowel) cancer surgery while placed in a steep head-down position with legs raised in stirrups. Researchers measured blood flow and oxygen in the calf muscles during the operation to understand how a rare but serious leg injury cal…
Sponsor: University of Portsmouth • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Real-World surgery study aims to improve fistula care
Knowledge-focused CompletedThis study tracked 646 people with complex fistulas (abnormal tunnels) caused by Crohn's disease or other conditions. Researchers observed the standard surgical treatments patients received at their clinics and recorded outcomes like fistula closure and complications. The goal is…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Which rectal cancer treatment leads to better surgery outcomes?
Knowledge-focused CompletedThis study looked at 57 patients with rectal cancer to compare surgical outcomes from three different treatment approaches: the RAPIDO protocol (short-course radiation plus chemotherapy), standard long-course radiation with chemotherapy, and surgery alone. Researchers measured th…
Sponsor: Sengkang General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Frailty check may predict surgery outcomes in colorectal cancer patients
Knowledge-focused CompletedThis study looked at 200 older adults (65+) having planned surgery for colorectal cancer. Researchers used a frailty test before surgery to see if it could predict complications like infections or longer hospital stays. The goal is to help doctors better plan care and reduce risk…
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Can a custom exercise plan help cancer patients on chemo? small study says maybe
Knowledge-focused CompletedThis study tested whether a flexible, personalized exercise program is practical for cancer patients receiving chemotherapy. Twenty-one adults with breast, ovarian, or colorectal cancer took part. The main goal was to see if patients would join, attend, and stick with the exercis…
Phase: NA • Sponsor: University of Dublin, Trinity College • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Hidden Gut-Brain issues common in kids with IBD, study finds
Knowledge-focused CompletedThis completed Italian study looked at how often children with inactive inflammatory bowel disease (IBD) also have disorders of gut-brain interaction (DGBIs), like irritable bowel syndrome. Researchers used the Rome IV questionnaire to compare 220 children with quiescent IBD to h…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Healthy stool study aims to sharpen IBD diagnosis
Knowledge-focused CompletedThis study measured calprotectin, a protein in stool that signals gut inflammation, in 121 healthy adults aged 22 and older. Participants collected a single stool sample at home and mailed it in. The goal is to establish what level is normal, helping doctors better tell apart inf…
Sponsor: American Laboratory Products Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Decades of data reveal shifting surgery trends in kids with IBD
Knowledge-focused CompletedThis study reviewed medical records of 966 children diagnosed with Crohn's disease or ulcerative colitis between 1988 and 2011. Researchers looked at how often children needed surgery and how treatments like immunosuppressants and anti-TNF drugs were used over time. The goal was …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New biologics for Crohn's: do they work? study reveals clues
Knowledge-focused CompletedThis completed study from China looked at 50 adults with Crohn's disease who were treated with two newer biologic drugs, Ustekinumab and Vedolizumab. The goal was to see how well these drugs control the disease and what factors might predict a good response. By analyzing past med…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Hidden danger: routine MRI spots silent fistulas in Crohn's patients
Knowledge-focused CompletedThis completed observational study looked at 669 Crohn's disease patients to see if finding hidden anal fistulas early with MRI leads to better long-term health. Researchers compared patients who had no symptoms but were found to have fistulas on MRI to those who had symptoms. Th…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Home workouts may boost cancer Patients' cell power
Knowledge-focused CompletedThis study looked at how prostate and colorectal cancer affect mitochondria—the energy factories in cells—and whether a 4-week home exercise program could improve them. Fifteen men awaiting surgery did either resistance or high-intensity interval training at home. Researchers mea…
Phase: NA • Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
HIV-Positive men studied to unlock anal cancer prevention
Knowledge-focused CompletedThis study followed 516 HIV-positive men who have sex with men over two years to track anal HPV infection and related lesions. Researchers used exams and anoscopy to see how often high-grade lesions appear or go away on their own. The goal is to gather evidence to better prevent …
Phase: NA • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
AI + cuff boosts polyp detection in colonoscopy trial
Knowledge-focused CompletedThis study tested whether using an artificial intelligence system (ENDOAID) together with a small attachment on the colonoscope (Endocuff) helps doctors find more precancerous polyps (adenomas) than using AI alone. Over 1,700 adults aged 45-85 undergoing colonoscopy for screening…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Kids with IBD: are they less fit than their peers?
Knowledge-focused CompletedThis study looked at physical fitness in 100 children and teens (ages 10-17) with chronic inflammatory bowel disease (Crohn's disease, ulcerative colitis, or unclassified colitis) and compared them to healthy kids of the same age, weight, and sex. Researchers measured cardiorespi…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study checks if IBD drug skyrizi seeps into breast milk
Knowledge-focused CompletedThis study looked at how much of the drug risankizumab (Skyrizi) passes into the breast milk of women with inflammatory bowel disease (IBD). Ten breastfeeding mothers who were already taking the drug provided milk samples over several weeks. The goal is to understand potential ex…
Phase: PHASE4 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Stool tests could make IBD monitoring easier and cheaper
Knowledge-focused CompletedThis study looked at 120 adults with inflammatory bowel disease (IBD) to see if simple stool tests can tell if the disease is active or in remission, just like a colonoscopy does. Colonoscopy is the current gold standard but is expensive, invasive, and not ideal for frequent chec…
Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Walnut wonder: daily snack may reshape gut bacteria and fight colon cancer
Knowledge-focused CompletedThis study looked at whether adding walnuts to your diet can change the bacteria in your gut and reduce signs of colon cancer risk. About 140 people at higher risk for colorectal cancer ate walnuts for a month. Researchers measured changes in gut bacteria, blood markers, and colo…
Phase: NA • Sponsor: UConn Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Can a standardized care framework improve life for colorectal cancer patients?
Knowledge-focused CompletedThis study looked at whether using a standardized set of measurements, including patient-reported outcomes, can improve care for people with colorectal cancer. Researchers followed 133 patients over time, collecting data on their health and quality of life. The goal was to see if…
Sponsor: IHU Strasbourg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Could the pill ease IBD Flare-Ups? new study investigates
Knowledge-focused CompletedThis study looked at how hormonal birth control might help manage inflammatory bowel disease (IBD) symptoms that get worse during a woman's period. Researchers surveyed 50 women with IBD to understand their preferences for birth control and whether they would join a future trial.…
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New EHR tool aims to boost Heart-Health talks for cancer survivors
Knowledge-focused CompletedThis study tested a tool built into electronic health records that prompts doctors to discuss heart health with cancer survivors during routine visits. Researchers enrolled 645 survivors of breast, prostate, colorectal, endometrial, and lymphoma cancers across 12 clinics. The goa…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Blood markers may reveal chemo response in just weeks
Knowledge-focused CompletedThis study looked at 74 people with metastatic colorectal cancer starting their first chemotherapy. Researchers took blood samples early in treatment to measure three markers: CEA, circulating tumor DNA, and total cell-free DNA. The goal was to see if early changes in these marke…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Immune cell clues in colon cancer could forecast recurrence risk
Knowledge-focused CompletedThis study followed 56 patients who had surgery for non-metastatic colon cancer to see if the number and type of immune cells in their tumors could predict whether the cancer would come back. Researchers analyzed both blood samples and tumor tissue for various immune markers. The…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New genetic test may predict colon cancer return
Knowledge-focused CompletedThis study looked at whether a genetic test called QMPSF can help predict if stage II or III colon cancer will come back after surgery. Researchers analyzed tumor tissue from 401 patients for specific DNA changes. The goal was to see if these genetic markers are linked to cancer …
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Gene combo clues could spot High-Risk colon cancer families
Knowledge-focused CompletedThis study looks at whether certain combinations of genetic variations, rather than a single gene, can increase the risk of colorectal cancer. Researchers will compare the DNA of 700 patients with strong family histories of the disease against 350 healthy controls. The goal is to…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Study reveals what makes patients happier during cancer screening
Knowledge-focused CompletedThis study looked at 846 people who had a positive stool test for colorectal cancer and needed a follow-up colonoscopy. Researchers wanted to understand how involved patients felt in making decisions about their care and how satisfied they were with the entire screening and treat…
Sponsor: Corporacion Parc Tauli • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New biomarker may predict which cancer drugs work best
Knowledge-focused CompletedThis completed study tested whether a new biomarker called 'mass response' can predict how well a cancer therapy will work. Researchers collected tumor cells from 72 patients with various cancers through fluid drainage or biopsies. The goal was to see if this biomarker could guid…
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
500 patients studied to uncover why colorectal cancer survival varies by region
Knowledge-focused CompletedThis study looked back at the medical records of 500 people with colorectal cancer from two regions in China. Researchers collected information on patients' backgrounds, lifestyle, and treatments to find patterns that affect survival. The goal was to understand regional differenc…
Sponsor: Qianfoshan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Scientists seek new clues to tame tough colorectal cancer
Knowledge-focused CompletedThis completed study looked at 29 patients with a hard-to-treat form of advanced colorectal cancer. The goal was to find new ways to group these patients based on the biology of their tumors. This could help doctors choose more effective treatments in the future. The study did no…
Sponsor: Cancer Trials Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can genes predict colorectal cancer drug success?
Knowledge-focused CompletedThis study looked at 76 adults with advanced colorectal cancer to find genetic markers that might predict how well a combination of chemotherapy (FOLFOX) and the drug bevacizumab works. The goal was to understand which patients benefit most, not to test a new cure. Participants h…
Sponsor: Cancer Trials Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Teens and parents share feelings on genetic risk results
Knowledge-focused CompletedThis study explored how teenagers and their parents react emotionally and mentally when they learn about genetic risks for conditions like hereditary breast cancer, Lynch syndrome, or high cholesterol. Researchers surveyed 162 participants using questionnaires and interviews to m…
Phase: EARLY_PHASE1 • Sponsor: Geisinger Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Which position makes colonoscopy easier? new study investigates
Knowledge-focused CompletedThis study tested whether starting a colonoscopy with the patient lying on their back (supine) or on their left side (left-lateral) makes a difference. Researchers measured how long it took to complete the procedure, how much pain patients felt, and how difficult the procedure wa…
Phase: NA • Sponsor: Celal Bayar University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New study aims to help nurses talk about sex with men who have IBD
Knowledge-focused CompletedThis study aims to create a tool that helps nurses better assess and care for the sexual health needs of men with inflammatory bowel disease (IBD). The research involved 792 participants, including men with IBD and their partners, as well as healthcare professionals. The goal is …
Sponsor: York Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Could T-DXd outperform standard care for multiple HER2-Positive cancers? new study investigates
Knowledge-focused CompletedThis study looks at whether the drug T-DXd works better than standard treatments for people with several types of HER2-positive solid tumors. Researchers will compare data from previous T-DXd trials with real-world medical records of patients who received standard care. The goal …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Rural cancer survivors test DIY care plans and phone education
Knowledge-focused CompletedThis study looked at whether cancer survivors living in rural areas can create their own survivorship care plans and learn from telehealth education. 261 survivors of breast, colorectal, lung, lymphoma, or prostate cancer took part. The goal was to see if this approach improves t…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Could your diet change gut bacteria and raise colon cancer risk?
Knowledge-focused CompletedThis study looked at how two different diets affect gut bacteria and markers linked to colon cancer risk in 15 African American adults at higher risk. Participants ate a high-fat, animal-based diet and a low-fat, plant-based diet for three weeks each. Researchers measured changes…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Protein PHGDH may predict immunotherapy success in colorectal cancer
Knowledge-focused CompletedThis completed study from West China Hospital examined tumor tissue from 100 colorectal cancer patients who had already received immunotherapy. Researchers measured levels of a protein called PHGDH to see if it was linked to how well the patients responded to treatment and how lo…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New study aims to improve anal cancer screening for At-Risk groups in thailand
Knowledge-focused CompletedThis study looked for the most effective and practical way to screen for anal high-grade lesions (a precancerous condition) in Thai men who have sex with men and transgender women. Researchers tested different screening methods in 950 participants to see which approach finds the …
Phase: NA • Sponsor: Institute of HIV Research and Innovation Foundation, Thailand • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Spina bifida bowel troubles: scientists probe nerve and gut lining
Knowledge-focused CompletedThis study looked at 36 adults with spina bifida to understand why they often have bowel issues. Researchers took small tissue samples from the colon during a routine scope and measured how the rectum works. The goal was to see if nerve damage affects the gut's lining and nerves,…
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Can a simple lesson boost colon cancer screening rates?
Knowledge-focused CompletedThis study gave educational materials about colorectal cancer and screening to 188 adults aged 45-75 in the Tampa Bay area. Researchers used surveys to measure changes in knowledge and screening intentions. The goal was to see if education encourages people to talk to their docto…
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
AI and balloon scope team up to spot more polyps in colon cancer screening
Knowledge-focused CompletedThis study looked at whether using a special balloon-assisted scope (G-Eye) together with artificial intelligence (CAD-Eye) finds more polyps than a standard colonoscopy with AI alone. About 300 people aged 50-74 who had a positive stool test took part. The goal was to see if the…
Sponsor: Elsan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Can an online program help african american women learn their genetic cancer risk?
Knowledge-focused CompletedThis completed study tested whether an online self-guided program could effectively return genetic test results for hereditary breast and ovarian cancer to African American women. Over 900 women from the Black Women's Health Study were offered their results online or by printed m…
Phase: NA • Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Emergency surgery in pregnancy: new study aims to understand fetal outcomes
Knowledge-focused CompletedThis study looked at how emergency general surgery affects pregnant women and their unborn babies. Researchers planned to follow pregnant women who needed surgery for problems like appendicitis or gallbladder disease. The goal was to learn more about the safety of these surgeries…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Surgery ventilation study aims to find the sweet spot for lung health
Knowledge-focused CompletedThis completed study looked at 101 adults having laparoscopic colorectal surgery under general anesthesia. Researchers tested different levels of positive end-expiratory pressure (PEEP) after a lung recruitment maneuver to see how long the benefits lasted and how it affected hear…
Phase: NA • Sponsor: Northern Jiangsu People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Which cancer follow-up care model works best? large study seeks answers.
Knowledge-focused CompletedThis study looked at nearly 1,000 cancer survivors to find out which follow-up care model works best for their quality of life and satisfaction. Participants were breast, prostate, or colorectal cancer survivors who had finished active treatment. Researchers compared different ca…
Sponsor: George Washington University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Gentler lung ventilation during surgery may tame tumor inflammation, early study hints
Knowledge-focused CompletedThis study tested whether a lung protective ventilation strategy (a gentler way of breathing during surgery) affects inflammation around tumors and certain blood markers in 60 colorectal cancer patients. Half received standard ventilation, half received the protective method. Res…
Phase: NA • Sponsor: Affiliated Hospital of Nantong University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
HIV cancer study reveals who gets sick and why
Knowledge-focused CompletedThis study looked at 460 people with HIV to see what types of cancer they have and why some choose to join cancer clinical trials. Researchers tracked cancers like Kaposi sarcoma, lymphoma, and HPV-related tumors. They also used surveys to learn how HIV and cancer treatments affe…
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Muscle loss linked to worse surgery outcomes in colorectal cancer patients
Knowledge-focused CompletedThis study looked at 70 adults with colorectal cancer to see how common muscle loss (sarcopenia) is before surgery and whether it leads to more complications or longer hospital stays. Researchers measured muscle strength, mass, and physical performance. The goal is to find patien…
Sponsor: Mersin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Biomarkers may guide personalized pain relief for kids
Knowledge-focused CompletedThis study looked at 163 children aged 7-12 with chronic abdominal pain to see if simple tests (biomarkers) could predict whether they would benefit more from cognitive behavioral therapy (CBT) or a low FODMAP diet. The goal was to personalize treatment and improve symptoms and q…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New study tracks hidden struggles of rectal cancer patients
Knowledge-focused CompletedThis study followed 107 adults newly diagnosed with rectal cancer to see how their symptoms, balance, and quality of life changed over time. Researchers used questionnaires to track bowel issues, emotional distress, and balance problems. The goal was to better understand these ch…
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Social media messages tested to boost colon cancer screening
Knowledge-focused CompletedThis study tested how different social media messages influence people's plans to get screened for colorectal cancer. Over 2,000 participants completed a 15-minute survey after seeing one of several message types. The goal was to see which messages made people more likely to foll…
Phase: NA • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Oxygen delivery during surgery linked to leak risk in colon cancer patients
Knowledge-focused CompletedThis study looked at 100 adults having laparoscopic surgery for colon cancer to see if the amount of oxygen delivered to tissues during the procedure affects the risk of a leak where the bowel is reconnected. Researchers measured oxygen delivery using a non-invasive monitor. The …
Sponsor: Saint Camillus International University of Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New study sheds light on daily struggles after rectal cancer surgery
Knowledge-focused CompletedThis study looked at how people feel and function after a two-step surgery for rectal cancer. Researchers followed 65 patients to measure bowel symptoms and their impact on quality of life one year after the final reconstruction. The goal is to identify which patients may have wo…
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
PET scans may improve chemo decisions for abdominal cancer patients
Knowledge-focused CompletedThis pilot study looked at whether repeated FDG-PET/CT scans can help select patients and evaluate how well a special chemotherapy (PIPAC) works for cancer that has spread to the lining of the abdomen. 34 patients with various abdominal cancers were included. The goal was to see …
Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New blood test could spare colon cancer patients unnecessary chemo
Knowledge-focused CompletedThis completed study tested a blood test that looks for tiny cancer leftovers after surgery in 175 people with stage II or III colorectal cancer. The goal was to see if the test could identify who really needs chemotherapy. If it works, it could help personalize treatment and avo…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Large french study tracks regorafenib use in Tough-to-Treat colorectal cancer
Knowledge-focused CompletedThis study followed 704 adults with metastatic colorectal cancer who received regorafenib through a French compassionate-use program. Researchers measured how long patients lived after starting the drug and collected data on tumor characteristics and prior treatments. The goal wa…
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Antibiotics may temporarily alter gut nerve cells, new study finds
Knowledge-focused CompletedThis study looked at how a short course of antibiotics changes the nerve and glia cells in the lower gut of 10 healthy adults. Researchers took colon tissue samples before and after antibiotic treatment to count these cells and measure gene activity. The goal was to understand if…
Phase: PHASE4 • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New study reveals hidden risks of colorectal cancer return after 5 years
Knowledge-focused CompletedThis study looked at 598 people who had surgery to remove colorectal cancer with the goal of curing it. Researchers wanted to understand how often the cancer comes back after five years and where it returns. The goal is to use this information to create better follow-up care plan…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Are IBD drugs safe in pregnancy? large french study investigates
Knowledge-focused CompletedThis study analyzed data from over 8,700 pregnant women with inflammatory bowel disease (Crohn's or ulcerative colitis) to see how well doctors follow guidelines when prescribing antiTNFα drugs and whether the benefits outweigh the risks for both mother and baby. Researchers look…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can surgery go green? study measures carbon footprint of appendix removal
Knowledge-focused CompletedThis study looked at how sustainable laparoscopic appendectomy is by measuring its environmental impact (carbon emissions), cost, and health benefits. Researchers followed 63 patients in Chile who had surgery for acute appendicitis. The goal was to create a single score that comb…
Sponsor: Universidad de La Frontera • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Michigan study tests ways to boost genetic testing in cancer patients
Knowledge-focused CompletedThis study looked at whether a special website or coaching phone calls could help more people with a personal or family history of certain cancers get genetic testing. Over 800 participants were randomly assigned to one of these two methods or to standard care. The goal was to se…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
AI learns from 600 colonoscopies to spot polyps
Knowledge-focused CompletedThis study gathered real-world videos and images from 600 adults undergoing screening or surveillance colonoscopies. The data will be used to develop and test artificial intelligence systems that can help doctors detect colon polyps. The study is complete and focused on data coll…
Sponsor: Olympus Europe SE & Co. KG • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New scan may tell rectal cancer patients if they can skip surgery
Knowledge-focused CompletedThis completed phase 2 study tested whether a new type of PET scan (FAPI-PET/CT) can accurately predict if rectal cancer has completely disappeared after a combination of short-course radiation, immunotherapy, and chemotherapy. Fifty-two patients with locally advanced rectal canc…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Which scope spots trouble better? study tests two colonoscopy techniques for IBD patients
Knowledge-focused CompletedThis study looked at 211 adults with long-standing inflammatory bowel disease (IBD) to see which colonoscopy method finds precancerous growths better: high-definition white light or dye spraying. Participants had IBD for at least eight years. The goal was to improve cancer screen…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Chatbot coaches cancer survivors on genetic testing
Knowledge-focused CompletedThis study tested a digital chatbot (called CATALYST) to help cancer survivors learn about genetic testing for inherited cancer risk. Fifty adults who had certain cancers (like breast, ovarian, or prostate) used the chatbot or received usual care. The goal was to see if the chatb…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New study reveals risk factors for rectal cancer's return after salvage surgery
Knowledge-focused CompletedThis study looked at 298 patients who had surgery for rectal cancer that came back in the same area. The goal was to find out how often the cancer returns again and what factors increase that risk. Researchers tracked long-term survival and identified key risk factors to help gui…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Study examines best sequence of treatments for advanced bowel cancer
Knowledge-focused CompletedThis study looks at data from 121 people with metastatic colorectal cancer who received two approved treatments—regorafenib and TAS (with or without bevacizumab)—in different orders. Researchers want to see which sequence works better and how long patients live. Since this is an …
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Study reveals hidden risks for polyp regrowth after colonoscopy
Knowledge-focused CompletedThis study reviewed the medical records of 255 adults who had colorectal polyps removed during a colonoscopy. The goal was to find out which factors, such as how the polyp was removed or its tissue type, make it more likely to come back. Researchers also tracked any complications…
Sponsor: University of Sao Paulo • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New program aims to close colon cancer gap in african americans
Knowledge-focused CompletedThis study tested an 11-step community program to help African Americans get screened for colorectal cancer. The program included education, risk assessment, and help with barriers like cost, transportation, and scheduling. 163 participants joined, and the study measured whether …
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Swiss study tests if doctor training boosts colon cancer screening
Knowledge-focused CompletedThis pilot study tested whether training primary care doctors in shared decision-making could increase colorectal cancer screening rates. Doctors in quality circles received evidence summaries, decision aids, and stool test kits to help patients choose between colonoscopy and FIT…
Phase: NA • Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Second chance surgery for rectal cancer: what predicts success?
Knowledge-focused CompletedThis study looked at 143 people in China who had a second surgery after rectal cancer treatment because of a leak or tumor return. Researchers wanted to find out what factors help the surgery succeed and whether patients can regain the ability to poop normally. The goal is to bet…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New device aims to sharpen polyp measurements for trainee doctors
Knowledge-focused CompletedThis study tested a device called Napoleon to help gastroenterology fellows measure colon polyps more accurately during colonoscopies. 46 patients aged 45 and older participated. The goal was to see if using the device improves measurement accuracy compared to just looking, which…
Phase: EARLY_PHASE1 • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Patch vs. pill: new ozanimod skin patch tested in healthy volunteers
Knowledge-focused CompletedThis study tested a new way to deliver the drug ozanimod using a skin patch instead of oral capsules. 24 healthy adults either took one capsule or wore a patch for 7 days. Researchers measured drug levels in the blood and checked for skin reactions to see if the patch works well …
Sponsor: Corium Innovations, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Can a simple dye prevent deadly leaks after colon cancer surgery?
Knowledge-focused CompletedThis study looked at whether using a special dye (indocyanine green) during laparoscopic surgery for colon or rectal cancer can help surgeons see blood flow in real time and reduce the risk of a dangerous leak where the bowel is reconnected. Researchers compared 115 patients who …
Sponsor: Jagiellonian University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Blood test may help overcome barriers to colon cancer screening
Knowledge-focused CompletedThis completed study with 297 participants examined if offering a blood-based screening test (Guardant Shield) encourages people who previously avoided stool tests or colonoscopy to get screened for colorectal cancer. Participants were adults aged 45-75 at average risk who had no…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Simple frailty quiz may help predict chemo risks for seniors with stomach or bowel cancer
Knowledge-focused CompletedThis study looked at whether two simple frailty questionnaires (G8 and VES-13) can predict serious side effects from chemotherapy in people 65 and older with gastrointestinal cancers. Researchers followed 72 patients receiving standard chemotherapy and checked their frailty, nutr…
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Large study looks at how a 25-Gene cancer test affects patients and families
Knowledge-focused CompletedThis study looked at how a genetic test that checks 25 genes linked to hereditary cancers is used in clinics. Over 1,500 people with a personal or family history of cancer took part. Researchers collected blood samples and had participants fill out questionnaires over five years …
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Hidden virus in Kids' guts: new study sheds light on CMV and IBD
Knowledge-focused CompletedThis study looked at 139 children having a colonoscopy to see how often the CMV virus is found in their gut tissue and blood. Some children had inflammatory bowel disease (Crohn's or colitis) and some did not. The goal was to learn which tests best detect CMV in the gut, helping …
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Can a picture help you understand your genetic risk?
Knowledge-focused CompletedThis study tested how well people understand genetic risk when shown different visual aids. Over 1,000 participants viewed either a single side-by-side chart or a step-by-step narrative with pictures. They then estimated their risk and answered questions about how they felt and w…
Phase: NA • Sponsor: Stephanie B. Seminara, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Artery size may predict cancer spread in rectal cancer patients
Knowledge-focused CompletedThis study looked at 690 rectal cancer patients to see if the size of a specific artery (the middle rectal artery) on MRI scans could help predict whether cancer has spread to nearby lymph nodes. The goal was to create a tool that helps doctors decide if more extensive surgery is…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
AI and navigators team up to boost colon cancer screening in poor neighborhoods
Knowledge-focused CompletedThis study tested whether a program that uses computer algorithms to identify people who are overdue for colorectal cancer screening, combined with a patient navigator to help them schedule and complete the test, could increase screening rates. The study included 385 adults livin…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Timing is everything: study links treatment delays to colorectal cancer survival
Knowledge-focused CompletedThis study looked at 227 people with colorectal cancer that had spread to the lining of the belly. Researchers wanted to see if waiting longer between chemotherapy and surgery affected how long patients lived without the cancer coming back. The goal is to find the best timing for…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Real-Time margin check during rectal cancer surgery may cut recurrence
Knowledge-focused CompletedThis study tested whether checking the removed tissue during surgery (frozen section) helps ensure all cancer is removed in people with mid or low rectal cancer who had radiation therapy. 99 patients were split into two groups: one had the extra check, the other had standard surg…
Phase: NA • Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New study explores how digital tools can personalize cancer care
Knowledge-focused CompletedThis study looked at how a digital care planning tool (eHNA) can help personalize care for people with colorectal cancer. Researchers interviewed 76 patients and clinicians to understand what works and what doesn't. The goal was to identify best practices for using digital tools …
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Massive study seeks safer chemo recovery for thousands
Knowledge-focused CompletedThis study looked at 3000 cancer patients to see which treatments work best for preventing dangerously low white blood cell counts after chemotherapy. It compared different approaches to see how well they prevent infections and improve quality of life. The goal is to give doctors…
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Blood test may spot polyp cells that signal cancer risk
Knowledge-focused CompletedThis study tested whether a blood test can find tumor cells or substances released by intestinal polyps. Researchers compared blood samples from 120 people with and without polyps during a colonoscopy. The goal is to see if these markers could help predict or monitor cancer sprea…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Sitting linked to gut bacteria changes and polyp growth, study finds
Knowledge-focused CompletedThis study looked at 80 adults aged 40-60 to see if sitting for long periods slows down gut transit time and changes gut bacteria in ways that could lead to colon polyps. Participants wore activity monitors, ate blue muffins to track digestion time, and provided stool samples. Th…
Sponsor: Clínica Universidad de los Andes • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Scientists hunt for biomarkers to personalize cancer therapy
Knowledge-focused CompletedThis completed study analyzed tumor and blood samples from 160 people with esophageal or rectal cancer. Researchers looked for genetic markers in the EGFR signaling pathway that might predict how well a patient responds to chemoradiotherapy given before surgery. The goal is to be…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Fatty acid intake linked to colon cancer risk in new study
Knowledge-focused CompletedThis study looked at whether eating certain fats (polyunsaturated fatty acids) is linked to colorectal cancer risk. Researchers measured fatty acids in fat tissue and blood samples from 551 people with and without colorectal cancer. The goal was to find reliable biomarkers that c…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Gene clues could personalize ulcerative colitis treatment
Knowledge-focused CompletedThis completed study examined whether differences in the IL-7 receptor gene are linked to the risk of developing ulcerative colitis and how well patients respond to the drug vedolizumab. Researchers enrolled 898 people, including those with UC and healthy controls, and analyzed t…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Can a recovery checklist help appendix patients go home sooner?
Knowledge-focused CompletedThis study observed 193 adults who had emergency laparoscopic appendix surgery for uncomplicated appendicitis. Researchers wanted to see how closely hospitals followed a specific recovery plan called RICA (an ERAS pathway) and whether early discharge within 24 hours was safe and …
Sponsor: Hospital Galdakao-Usansolo • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Quick video training boosts cancer detection in polyps, study finds
Knowledge-focused CompletedThis study tested whether a short training video on 'blink features' (visual clues like redness or ulcers) could help medical students and non-gastroenterology trainees better detect cancer in images of colon polyps. 65 participants completed an online survey before and after wat…
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Which colon cancer surgery is better? new study compares techniques
Knowledge-focused CompletedThis study compared two types of laparoscopic surgery for early-stage colon cancer: conventional colectomy and complete mesocolic excision (CME). Researchers looked at 150 patients in Upper Egypt to see which surgery removed more lymph nodes and caused fewer complications. The go…
Phase: NA • Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Blood test may boost colorectal cancer screening in reluctant patients
Knowledge-focused CompletedThis study tested whether offering a simple blood test instead of a colonoscopy or stool test would encourage more people to get screened for colorectal cancer. Researchers enrolled 297 adults aged 45-75 who had previously skipped or refused traditional screening. The goal was to…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Nurses step up: study tests if they can replace doctors for chemo checkups
Knowledge-focused CompletedThis study looked at whether a nurse practitioner can safely monitor people with colorectal cancer who are getting intravenous chemotherapy, compared to a doctor. About 207 adults took part. The goal was to see if the number of serious side effects and quality of life were simila…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New plan aims to catch dangerous leaks after colon surgery
Knowledge-focused CompletedThis study tested a step-by-step plan for patients who had high C-reactive protein (CRP) levels after surgery for colorectal cancer. High CRP can signal a serious complication called an anastomotic leak, where the surgical connection leaks. The goal was to see if a proactive mana…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Blood test holds promise for colorectal cancer screening
Knowledge-focused CompletedThis study looked at whether proteins in the blood can help screen for colorectal cancer. Researchers tested blood samples from 350 people aged 50 and older who were already scheduled for a colonoscopy. The goal was to see if certain protein markers could reliably detect advanced…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Study reveals artery stiffness from common cancer drug
Knowledge-focused CompletedThis study looked at how bevacizumab, a drug used to treat advanced colorectal cancer, affects the stiffness of arteries. Researchers measured artery stiffness in 13 patients before and after 4 months of treatment. The goal was to better understand the drug's cardiovascular side …
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
What drives cancer patients to get a second opinion?
Knowledge-focused CompletedThis study looked at 236 adults with breast, colorectal, or pancreatic cancer who sought a second opinion at the University of Colorado. Researchers reviewed medical records to see if patients stayed for treatment or went elsewhere. The goal was to understand what factors influen…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Rural education program aims to increase cancer screening
Knowledge-focused CompletedThis study tested an educational program to help people in rural areas learn more about colorectal cancer screening. 205 adults aged 45-74 from specific counties in New Hampshire and Vermont took part. Researchers measured changes in knowledge and intentions to get screened befor…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New lymph node map could sharpen colon cancer prognosis
Knowledge-focused CompletedThis completed study analyzed data from 1,500 colon cancer patients to see if a new way of classifying lymph node involvement—based on both the number and location of affected nodes and tumor deposits—can better predict survival than the current standard system. Researchers colle…
Sponsor: Cai Zerong • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
10-Year study sheds light on best surgical approach for kids with severe appendicitis
Knowledge-focused CompletedThis study looked back at 765 children with complicated appendicitis treated over ten years. Researchers wanted to see how well laparoscopic surgery works for different types of the condition, including cases with abscess or mass. The goal is to help doctors decide the best treat…
Phase: NA • Sponsor: Mohammad Daboos • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Cancer moonshot study banks tissue to unlock genetic secrets
Knowledge-focused CompletedThis completed study collected blood and tumor tissue from 64 patients with advanced cancers (like melanoma, breast, lung, and kidney cancer) to study genetic changes and treatment resistance. The samples are stored for future research, including genomic analysis. No new treatmen…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Early safety check for new c. diff drug in japanese volunteers
Knowledge-focused CompletedThis early-stage study tested a single dose of AZD5148, a potential treatment for C. difficile infection, in 16 healthy Japanese adults. The main goal was to see if the drug is safe and how the body processes it. Participants received either the drug or a placebo by injection and…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC